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while	being	part	 of	 the	Biological	 Systems	Engineering	 Laboratory.	All	 the	presented	
















been	 proven	 to	 improve	mass	 transport	 in	 the	 culture	 system,	 along	with	 removing	
cellular	waste.	To	overcome	heterogeneity,	finding	the	adequate	cells	and	proper	cues	
to	 drive	 osteogenic	 differentiation,	 are	 as	 important	 as	 the	 bioprocess	 to	 host	 the	
culture.	hDPSCs	are	a	promising	 source	of	 stem	cells	 for	 the	production	of	bioactive	






differentiation	 of	 hDPSCs	 encapsulated	 in	 alginate/	 gelatin	 hydrogel	 subjected	 to	
suspended	culture	in	a	novel	perfusion-RWV	bioreactor	was	studied,	and	compared	with	
traditional	fed-batch	and	static	culture	methodologies.	Finally,	the	effect	of	osteogenic	







osteogenesis	 in	 2D	 and	 3D.	 The	 novel	 high	 throughput	 perfusion-RWV	 bioreactor	
bioprocessing,	demonstrated	to	be	successful	in	the	mitigation	of	nutrient	and	oxygen	
transport	limitations,	external	to	three-dimensional	cell/alginate	constructs,	performing	
above	 fed-batch	 RWV	 bioreactor	 and	 static	 culture,	 and	 able	 to	 produce	 more	
homogeneous,	denser	and	functional	bone	constructs,	rich	in	mature	osteoblasts	and	
mineralising	 osteocytes.	 Both	 BMP2	 and	 simvastatin,	 demonstrated	 to	 enhance	 the	
quality	 of	 bone	 constructs	 produced	 by	 the	 perfusion-RWV	 unit,	 yielding	 more	
homogeneous	constructs,	with	higher	alkaline	phosphatase	activity,	mineralisation	and	
showing	a	more	mature	gene	pattern.	Interestingly.	BMP2	produced	constructs	rich	in	
mature	osteoblast,	while	simvastatin,	constructs	 rich	 in	osteocytes.	 In	particular,	 this	
experiment	proved	effective	in	producing	osteogenic	differentiation	with	minimal	use	
of	BMP2,	offering	a	potential	mean	to	avoid	dosage	dependant	safety	risks	of	BMP2.	





















and	 Clair	 Adjiman.	 In	 different	 ways,	 you	 reinforced	 and	 challenged	 me	 to	 be	 a	 better	



































































































































































































































































































































































































































increasing	 every	 year.	 A	 report	 from	 Global	 Industry	 Analysts	 (GIA),	 “Orthopaedic	
Prosthetics:	A	Global	Strategic	Business	Report”,	sets	the	global	orthopaedic	prosthetic	
market	 at	 £12.7	 billion	 and	 projects	 by	 2017	 the	market	 reaching	 £15.2	 billion.	 Yet,	




attack,	wear	and	mechanical	 loading,	and	due	 to	 lack	of	osseointegration	or	delayed	
union.	These	numbers	dramatically		rise	to	20%	for	high-impact	fractures	(NHFD,	2012,	
Brydone	 et	 al.,	 2010,	 Yuan	 et	 al.,	 2011).	 Furthermore,	 infections	 and	 rejections	 of	
















Polak	 et	 al.,	 2008,	 Placzek	 et	 al.,	 2009);	 and	 by	 designing	 and	 using	 different	













mesenchymal	 stem	 cell	 (MSCs	 from	 the	 neural	 crest),	 capable	 of	 differentiating	 into	
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osteoblasts,	 osteocytes,	 odontoblasts,	 adipocytes,	 chondrocytes	 and	 neural	 cells	
(Grottkau	 et	 al.,	 2010).	With	 high	 proliferation	 rates	 and	 ease	 in	 access.	 DPSCs	 are	
located	 in	the	cell-rich	zone	of	the	dental	pulp	of	adults’	teeth	(similar	to	the	human	
exfoliated	deciduous	stem	cells	(SHEDs)	in	babies).	Their	source	and	the	subtle	nature	




the	 body	 and	 implementing	 regenerative	 medicine.	 They	 can	 be	 suitable	 for	 bone	





















achieve	 bone	 mimicry,	 starting	 from	 undifferentiated	 hDPSCs	 in	 a	 3D	 environment.	
Ultimately,	 leading	 to	 the	 induction	 of	 the	 whole	 range	 of	 cells	 in	 the	 osteoblastic	
phenotype,	 from	 pre-osteoblasts	 to	 the	 terminally	 differentiated	 osteocytic	 cells	 to	
produce	cells	for	clinical	uses.		

































composite	 biomaterials	 of	 organic	 and	mineral	 nature.	 These	 share	 a	 basic	 building	
block,	 the	 hydroxyapatite	 crystals	 and	 the	 mineralised	 collagen	 fibrils.	 The	 most	
important	members	of	the	family	are	all	the	tissues	normally	called	bones;	but	cartilage,	
enamel,	dentin,	 cementum	and	mineralised	 tendons,	also	 form	part	of	 the	 family.	 In	
general,	bones	will	differ	in	the	proportions	of	the	common	components	(collagen	fibrils,	
hydroxyapatite	 crystals	 and	water)	 and	 in	 their	 structural	motifs/	 architecture	 at	 all	
levels	 of	 complexity.	 The	 diversity	 of	 structures	 they	 present,	 reflects	 their	 specific	
functionality,	 as	mechanical	 support	 and	 as	 reservoirs	 of	 calcium	 and	 phosphate	 for	
metabolic	functions	(Weiner	and	Wagner,	1998,	Jager	and	Fratzl,	2000).	
Bones	 are	 composed	 in	 20-30%	 in	 weight	 of	 an	 organic	 phase,	 60-70%	 of	 mineral	
substances	 and	 the	 remaining	 is	 water.	 The	 organic	 phase	 consists	 of	 mineralised	
collagen	fibrils,	non	collagenous	proteins	(around	200	different	types,	less	than	10%	of	




consists	only	of	hydroxyapatite	crystals	(𝐶𝑎# 𝑃𝑂&, 𝐶𝑂( ( 𝑂𝐻 ).		
The	skeleton	has	mainly	two	arranged	macro-architectural	 forms,	cancellous/	spongy	














constant,	 the	 increase	 of	 minerals	 proportion	 occurs	 at	 expense	 of	 water	 content.	
Furthermore,	 the	 mineral	 phase	 will	 increase	 with	 ageing	 as	 the	 crystals	 continue	




mineralised	 and	 un-mineralised	 fibrils,	 producing	 local	 alignment	 of	 crystal	 layers	 in	
adjacent	fibrils	(Weiner	and	Wagner,	1998).	The	fibres	organise	in	a	variety	of	pattern	
depending	 on	 their	 direction,	 the	 formation	 of	 clusters	 and	 how	 packed	 they	 are,	




matrix	of	 tunnels.	 These	are	 then	 refilled	by	 lamellar	bone	produced	by	osteoblasts,	
leaving	minuscule	channels	 that	work	as	blood	vessels	called	osteons	and	a	group	of	
even	 smaller	 channels	 called	 canaliculi,	 in	 them	 we	 find	 osteocytes	 with	 secretory	
function	that	will	exchange	nutrients	through	the	bones.		




















the	 surface	 of	 bone.	When	 these	 get	 surrounded	 and	 isolated	 by	 bone	matrix,	 they	
develop	into	osteocytes.	
Osteocytes	are	mature	osteoblasts.	They	are	 found	within	 the	bone	matrix,	confined	










primitive	 segment),	 precursor	 of	 the	 axial	 skeleton;	 the	 lateral	 plate	 mesoderm,	
precursor	of	limb	skeleton;	and	the	cranial	neural	crest,	precursor	of	the	branchial	arch,	
craniofacial	 bone	 and	 cartilage.	 Osteogenesis	 can	 occur	 following	 two	 different	
mechanisms:	 intramembranous	 ossification	 (IO),	 where	 mesenchyme	 differentiate	
directly	 into	 vascularised	 osteoblasts	 at	 ossification	 centres;	 or	 endochondral	
ossification	(EO),	 in	which	the	formation	of	mineralised	bone	 is	 intermediated	by	the	
development	 of	 a	 cartilaginous	 scaffold	 (Gilbert	 et	 al.,	 2000).	 Both	mechanisms	 are	
accompanied	 by	 the	 secretion	 of	 a	 complex	 extracellular	 matrix	 (collagen,	 bone	
sialoprotein,	 proteoglycans,	 other	 proteins	 and	 crystalline	 salts),	 that	 initiates	 tissue	
mineralisation	to	form	the	calcified	bone	(Heng	et	al.,	2004b).	
In	general,	bone	development	 involves	four	phases:	1)	the	migration	of	mesenchyme	






IO	 starts	 in	 the	 second	 month	 of	 embryogenesis,	 and	 is	 characteristic	 of	 the	
development	 of	 flat	 bones	 of	 the	 skull	 (e.g.	 frontal,	 parietal,	 occipital,	 and	 temporal	
bones)	 and	 the	 clavicles.	 Mesenchyme	 from	 the	 neural	 crest	 proliferates	 and	
differentiates	forming	dense	clusters	of	cells	called	“Ossification	Centres”.	The	cells	will	




















EO	 starts	 in	 the	 second	 month	 of	 embryonic	 development	 and	 will	 result	 in	 the	
formation	of	all	the	bones	of	a	human	being,	but	the	flat	bones	of	the	skull	and	clavicles	
(formed	 by	 IO).	 Bones	 are	 developed	 through	mesenchyme	 formation	 of	 a	 cartilage	
model,	 and	 its	 further	 breakdown	 and	 gradual	 replacement	with	 bone	 during	 foetal	
development	and	postnatal	growth	(Mackie	et	al.,	2008).	The	process	happens	in	five	
distinguishable	 stages.	 In	 the	 first	 stage,	 mesenchyme	 will	 proliferate,	 and	 get	
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committed	 to	differentiate	 into	hyaline	 cartilage	 (articular).	 In	 the	 second	 stage,	 the	
committed	 cells	 will	 flatten	 and	 aggregate	 into	 clusters	 and	 differentiate	 into	
chondrocytes	 (cartilage	 forming	 cells).	 In	 the	 third	 stage,	 the	 chondrocytes	 will	
proliferate	and	arrange	in	the	form	of	the	specific	bone	they	will	build.	The	cells	start	
secreting	cartilage	specific	extracellular	matrix.	In	stage	four,	the	chondrocytes	stop	the	
proliferation	 and	 start	 to	 grow.	 Increasing	 their	 volume	 dramatically,	 becoming	
hypertrophic	 chondrocytes.	 The	 matrix	 they	 secrete,	 contain	 collagen	 X	 and	 more	
fibronectin.	This	matrix	will	be	mineralised	with	carbonate	calcium.	In	the	fifth	stage,	
the	 cartilage	 scaffold	will	 be	 infiltrated	 by	 cells	 from	 the	 periosteum	 (layer	 of	 tissue	
surrounding	the	bone):	blood	vessels,	osteoclasts	(bone-resorbing	cells),	and	cells	with	
osteogenic	 (osteoblasts)	 and	 hematopoietic	 (bone	 marrow)	 properties.	 This	
“Ossification	 Front”	 forms	 the	 periosteal	 bud.	 The	 hypertrophic	 chondrocytes	 start	
dying	by	autophagic	cell	dead	and	are	resorbed	by	the	osteoclasts.	Later,	this	area	will	
become	 yellow	 bone	 marrow.	 Mesenchymal	 cells	 from	 the	 periosteum	 and	 the	
periosteal	 bud,	 start	 proliferating	 and	 secreting	 extracellular	 bone	 matrix	 (osteoid)	
attached	to	the	remnants	of	the	hyaline	cartilage	scaffold	left	by	the	osteoclasts.	The	
process	 starts	 from	 the	 centre	 (primary	 ossification	 centres),	 and	 propagates	 to	 the	
longitudinal	ends	(secondary	ossification	centres),	allowing	ossification	centres	to	form	
in	 the	 space	 where	 once	 cartilage	 was.	 Eventually	 all	 the	 cartilage	 is	 replaced	 by	
trabecular	bones,	except	at	the	articular	surfaces.	Where	hyaline	cartilage	remains	and	
the	 inner	part	where	the	marrow	cavity	 is	 formed	(Gilbert	et	al.,	2000,	Mackie	et	al.,	
2008).	 Further	development	makes	 the	external	 layers	 to	become	cortical	bone.	The	
remaining	 cartilage	 in	 the	 articular	 surfaces,	 will	 allow	 for	 the	 bone	 to	 grow	
longitudinally	during	post-natal	development	(Mackie	et	al.,	2008).		











require	 the	 commitment	 of	 the	 undifferentiated	multipotent	 cells	 to	 the	 osteogenic	
lineage,	 and	 the	 differentiation	 into	 pre-osteoblasts	 (osteoinduction)	 (Urist,	 1965,	
Albrektsson	 and	 Johansson,	 2001).	 Signalling	 pathways	 normally	 associated	 with	














to	 a	number	of	 bone	diseases	 (Chen	et	 al.,	 2012).	 They	 induce	and	are	essential	 for	
cartilage,	 tooth	 and	 bone	 formation,	 crystallisation	 and	 maturation,	 having	 major	
relevance	in	the	differentiation	of	stem	cells	in	vitro	and	in	vivo	into	osteogenic	lineage,	










Figure	 5	 The	 BMP	 and	 TGFβ	 canonical	 signalling	 pathways:	 BMPs	 contact	 surface	
receptor	BMPR-II,	forming	an	heterodimeric	complex	with	surface	receptor	BMPR-I,	
BMPR-I	gets	phosphorylated	and	interacts	with	the	transcription	regulators	R-SMADS	
(SMAD1/5/8)	 that	 react	 propagating	 the	 signal	 through	 C-SMAD	 (SMAD4)	 and	
translocate	to	the	nucleus,	then	they	interact	with	DNA	binding	proteins,	to	regulate	
gene	expression,	in	a	cascade	of	genes	(Runx2,	dlx5,	Msx2	will	trigger	Osterix)	that	will	




























































































































































































R-SMADS	 (SMAD2/3)	 that	 react	 propagating	 the	 signal	 through	 SMAD4	 and	
translocate	to	the	nucleus,	then	they	interact	with	DNA	binding	proteins,	to	regulate	
gene	 expression,	 in	 a	 cascade	 of	 genes	 (Runx2)	 that	 will	 lead	 to	 osteoblasts	
differentiation	 (Cai	 et	 al.,	 2012,	 Song	 et	 al.,	 2009,	 Yavropoulou	 and	 Yovos,	 2007).	
Dexamethasone	 through	 interacting	with	 the	glucocorticoid	 receptor	 (GCR)	protein	
suppressing	the	inhibitory	action	of	NFkB	(by	suppressing	TNF-α	signalling	inhibitory	
effect	and	its	NFkB	activation)	on	BMPs	induced	osteoblastic	differentiation	
BMPs	 and	 TGF-β	 signalling	 pathways	 are	 two	 highly	 interactive	 pathways,	 and	 their	
cross-talk	is	fundamental	in	the	osteoblastogenesis	and	osteoclastogenesis	(Chen	et	al.,	
2012).	Both	pathways	share	inhibitors	and	activators.	The	central	signal	messengers	for	





The	 BMP	 signal	 transduction	 requires	 the	 interaction	 between	 two	 distinct	 types	 of	
transmembrane	 receptors	 forming	 a	 complex	 (BMPR-II,	 a	 high	 affinity	 receptor	 for	
ligand	binding	and	BMPR-I,	an	activator	of	the	signal	transduction),	that	will	spread	the	
signal	 through	 the	 cytoplasm	 by	 the	 interaction	 of	 pathway	 restricted	 Smads	
(Smad1/5/8	or	 r-Smads)	and	common	mediator	Smads	 (Smad4	or	c-Smads)	 to	 finally	
translocate	 the	 signal	 to	 the	 nucleus	 and	 regulate/	 generate	 a	 cascade	 of	 gene	
expression	that	will	end	up	in	osteoblastic	differentiation.	The	binding	of	BMPs	to	BMPR-
II	 results	 in	transphosphorylation	and	activation	of	the	BMPR-I	by	BMPR-II,	activating	
the	 BMPR-I	 and	 the	 subsequent	 signalling	 by	 the	 heterodimeric	 receptor	 complex.	
BMPR-I	 will	 bind,	 phosphorylate	 and	 then	 activate	 the	 Smad1/5/8	 transcriptional	
regulator,	 which	 as	 well	 will	 bind	 and	 form	 a	 complex	with	 Smad4	 to	 subsequently	
translocate	 into	 the	 nucleus.	 Inside	 the	 nucleus,	 the	 r-Smad/c-Smad	 complex	 will	
directly	 interact	 with	 DNA	 as	 well	 as	 with	 DNA-binding	 proteins	 directing	 the	
transcription	 of	 the	 targeted	 genes.	 The	 gene	 cascade	 will	 start	 with	 Runt-related	
transcription	factor	2	(Runx2	or	CBFA1),	followed	by	expression	of	collagen	I	(Col1)	and	
osteopontin	 (OPN	 or	 Spp1),	 osterix	 (OSX)	 in	 the	 preosteoblast	 stage	 (Komori,	 2010,	
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Matsubara	et	al.,	2008).	Mature	osteoblasts	keep	expressing	Col1	and	start	expressing	






direct	 the	 preosteoblast	 to	 a	 mature	 stage	 (Komori,	 2010).	 After	 commitment	 to	
osteoblasts	lineage,	cells	will	express	different	bone	matrix	protein	genes,	depending	on	
the	stage	of	the	cell	development,	immature	preosteoblasts	will	weakly	express	collagen	
I	 (Col1)	 and	 in	 a	 higher	 level	 osteopontin	 (OPN	 or	 Spp1)	 and	 osterix	 (OSX),	 forming	
unpacked	woven	bone	(Komori,	2010,	Matsubara	et	al.,	2008).	Mature	osteoblasts	will	
strongly	express	Col1	and	osteocalcin	(Bglap),	forming	a	densely	packed	lamellar	bone.	











patterns	 in	 bone	 to	 be	 generated.	 In	 order	 to	 bio-mimic	 this	 tissue	 in	 vitro,	 these	
developmental	 pathways	 need	 to	 be	 studied,	 understood	 and	 controlled.	 A	 proper	
system	has	to	be	used	to	create	the	adequate	microenvironment,	that	will	enable	this	
to	happen.	Tissue	engineering	has	proven	to	be	a	discipline	with	all	the	tools	required	



















of	engineering	and	 life	 sciences	 for	 the	development	of	biological	 replacements	 that	
restore	damaged	tissue	function”	(Langer	and	Vacanti,	1993).	Furthermore	the	nature	
of	 TE	 research,	 positions	 improve	 functionality	 of	 tissues	 at	 a	 glance	 (Salgado	 et	 al.,	









autologous	 and	 allogeneic	 engraftments	 are	 used	 to	 help	 healing	 of	 fractures	 with	
partial	success.	These	methodologies	work	for	the	most	common	and	simple	cases,	but	
as	mentioned	in	the	previous	section,	there	is	an	important	number	of	cases	in	which	
they	 fail.	 For	 these	cases,	graft	 surface	enhancement	with	bioactive	osteoconductive	
growth	 factors,	has	been	 tried,	but	with	 limited	 success.	 The	 lack	of	 functional	 cells,	
hinders	 the	 inclusion	of	 the	grafts	 to	 the	metabolic	normal	mechanisms	of	 the	bone	











The	 use	 of	 living	 cells	 to	 produce	 biological	 substitutes	 to	 replace,	 repair	 and/	 or	
regenerate	 failing	 bone	 with	 functional	 living	 bone-alike	 constructs	 requires	 the	
growing/	fabrication/	implantation	of	bone	ex	vivo,	and/	or	the	growth	in	vivo	(Polak	et	
al.,	 2008).	 From	a	 cellular	perspective,	 the	actors	 involved	 in	bone	 regeneration	are:	






cells	 (ADSCs),	muscle-derived	stem	cells	 (MDSCs),	and	dental	pulp	stem	cells	 (DPSCs)	
(Seong	 et	 al.,	 2010,	 Peng	 et	 al.,	 2009,	 Polak	 et	 al.,	 2008,	 Placzek	 et	 al.,	 2009);	 and	
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manipulating	these	cells	in	vitro	and	in	2D	static	systems	it	has	been	possible	to	mimic	




However,	 researching	 cells	 on	 its	 own	 cannot	provide	 a	 comprehensive	 and	 suitable	




























of	 healthy	 cells,	 that	 could	 be	 easily	 isolated	 and	 expanded	 into	 required	 quantities	
(quality	 is	 age	 dependant),	 that	 is	 compatible	 with	 humans,	 and	 that	 with	 the	










The	 natural	 choice	 of	 cells	 with	 bone	 TE	 potential	 are	 Osteoblasts.	 These	 wouldn’t	
present	 an	 immunogenic	 reaction	 from	 the	 body	 when	 acquired	 autologously	 and	








come	 with	 immunogenic	 reactions	 and	 phenotypic	 mismatch,	 ultimately	 leading	 to	
rejection	of	the	tissue	and	further	health	complications.		
The	 early	 development	 of	 embryos	 and	 the	 self-repair	 mechanisms	 of	 the	 body,	
together	harbour	a	source	of	cells	that	complies	the	requirements	of	TE,	the	stem	cells.	
These	have	the	remarkable	potential	 to	expand	and	give	rise	to	all	 the	tissues	 in	 the	
body.	Being	in	charge	of	the	development	of	the	body	at	early	stage,	and	the	growth	
and	 regenerative	 processes	 after	 birth.	 Since	 their	 discovery,	 they	 have	 become	 an	
obvious	place	 to	 research	 for	alternative	 treatments	 to	 tackle	 the	disadvantages	and	
weaknesses	of	the	prosthetic	industry.	If	properly	handled	and	guided,	they	posses	the	
key	 to	 empowering	 the	 regenerability	 of	 the	 body,	 and	 ultimately	 of	 curing	 many	
different	diseases	and	injuries.	
To	choose	the	proper	source	of	cells,	it	has	to	be	considered:	1)	The	immune	response	








• Totipotent	 stem	 cells:	 cells	with	 the	 ability	 to	 give	 rise	 to	 all	 the	 cell	 lineages	 of	 an	
organism	(embryonic,	somatic,	and	germ	cells),	being	able	to	produce	a	hole	organism;	
in	mammalians	only	the	zygote	and	the	first	cleavage	blastomeres	are	totipotent.	
• Pluripotent	 stem	 cells:	 cells	 with	 the	 ability	 to	 give	 rise	 to	 the	 three	 germ	 layers	
(endoderm,	 mesoderm,	 ectoderm).	 In	 this	 group	 of	 cells	 we	 find	 the	 ESCs	 and	 the	
induced	pluripotent	stem	cells	(IPSs).	
• Multipotent	stem	cells:	adult	cells	with	the	ability	to	give	rise	to	multiple	cell	types	of	
one	 lineage.	 Good	 examples	 are	 the	 bone	marrow-derived	mesenchymal	 stem	 cells	
(BMSCs).	













are	 cells	 derived	 from	 the	 developing	 foetal	 gonadal	 ridge.	 Additionally,	 embryonal	







1988).	 In	 the	 absence	 of	 these	 conditions,	 ESCs	 lose	 its	 self-renewal	 capacity	 and	
pluripotency	and	do	not	persist	more	than	a	small	number	of	days.	Similar	observations	
were	made	by	Watanabe	et	al.	when	studying	human	ESCs	and	the	use	of	Rho	kinase	
(ROCK)	 inhibitor,	 when	 cultured	 with	 or	 without	 a	 growth	 inactivated	 feeder	 layer	
(Watanabe	et	al.,	2007,	Claassen	et	al.,	2009).	Therefore,	under	the	proper	conditions,	




Genetic	factor	 Name	 Family	 Function	












activation	 via	 LIF	 and	 glucoprotein	











al.,	 2012)	 where	 all	 the	 known	 pathways	 associated	 with	 pluripotency	 and	
differentiation	are	shown.	
None	of	these	pathways	suffice	to	sustain	the	self-renewal	and	pluripotency	of	hESCs,	










capable	of	 teratoma	 formation,	 the	differentiated	 fate	 they	 follow	 is	very	difficult	 to	














layers	 in	 vitro	 and	 in	 vivo.	 These	 express	 most	 of	 the	 markers	 associated	 with	
pluripotency,	 having	 epigenetic	 and	morphological	 characteristics	 similar	 to	 those	 of	
ESCs.	Although	 the	potential	of	 iPSCs	compared	with	 that	of	ESC	 fluctuates	between	
similar	 to	 less	 effective	 depending	 on	 the	 cell	 lines	 tested	 and	 the	 differentiation	
analyses	performed	(Bilousova	et	al.,	2011).	However,	 it	remains	to	be	demonstrated	
whether	both	 cell	 types	 rely	on	 similar	mechanisms	 to	maintain	pluripotency	and	 to	
drive	their	differentiation	(Vallier	et	al.,	2009).	
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Multipotent	 stem	 cells	 or	 adult	 mesenchymal	 stem	 cells	 (MDCs)	 are	 anchorage-














efficacy	 in	 healing	 cartilaginous,	 osseous,	 tendon	defects	 or	 even	 in	 treating	 genetic	
disorders	such	as	osteogenesis	imperfecta	or	Duchenne’s	muscular	dystrophy	(Schultz	
et	al.,	2000).	
MSCs	 sources,	 bone	 marrow-derived	 mesenchymal	 stem	 cells	 (BM-MSCs),	 umbilical	
cord	blood-derived	mesenchymal	stem	cells	(UCB-MSCs),	adipose	tissue-derived	stem	
cells	 (ADSCs),	muscle-derived	stem	cells	 (MDSCs),	and	dental	pulp	stem	cells	 (DPSCs)	
(Seong	 et	 al.,	 2010,	 Peng	 et	 al.,	 2009,	 Polak	 et	 al.,	 2008,	 Placzek	 et	 al.,	 2009);	 and	
manipulating	this	cells	they	have	been	able	to	produce	different	kinds	of	cell	 tissues.	
When	 stem	 cells	 are	 supplemented	 with	 hydrocortisone,	 insulin,	 T3,	 EGF,	 VD3	 and	
ascorbic	 acid,	 they	 differentiate	 into	 skin	 cells	 when	 grown	 in	 collagen/	 poly(l-lactic	
acid)–co-poly(3-caprolactone)	nanofibrous	scaffolds	(Jin	et	al.,	2011).	Moue	and	human	
SCs	 in	 vitro	 can	 be	 differentiated	 to	 neural	 cells,	 when	 cultured	 in	 growth-factor-
minimized	medium,	in	what	is	called	intrinsic	transition	(Kamiya	et	al.,	2011).	pigment	
cells,	cardiac	muscle,	bone	cells,	teeth	cells,	cartilage	cells,	tubule	cells,	pancreatic	cells,	




In	 the	postnatal	 state,	 cells	with	osteogenic	potential	persist	 in	 the	bone	marrow,	 in	
dental	 pulp	 and	 in	 other	 cell	 niches.	 They	 play	 an	 integral	 part	 in	 bone	 growth	 and	
remodelling,	as	well	as	in	bone	repair	during	postnatal	life	(Heng	et	al.,	2004b).	These	
cells	 continuously	 replicate,	 while	 some	 become	 committed	 to	 cell	 lineages	 such	 as	


























tissue	 regeneration	 therapies,	 DPSCs	 are	 self-renewing	 and	 able	 to	 express	markers	





Previous	 studies	 have	 shown	 the	 capability	 of	 DPSCs	 to	 regenerate	 their	
microenvironments	 with	 outstanding	 fidelity,	 including	 the	 surrounding	 mineralised	
structures	of	bone	and	dentin	(Shi	and	Gronthos,	2003),	being	able	to	differentiate	into	
bone-like	 constructs	 and	 dentin-pulp-like	 tissues	 when	 cultured	 with	 media	




Research	 has	 been	 done	 in	 search	 of	 the	 proper	 techniques	 for	 directing	 the	














































Results	 have	 shown	 that	 transforming	 growth	 factor	 (TGF-β)	 and	 5-Aza-20-
deoxycytidine	(DNA	demethylation	agent)	have	myogenic	action	(Maeda	et	al.,	2004,	
Nakatsuka	et	al.,	2010,	Song	et	al.,	2012,	d'Aquino	et	al.,	2007),	fibroblast	growth	factor	
β	 (bFGF)	 and	 epithelial	 growth	 factor	 (EGF),	 neural	 differentiability	 (d'Aquino	 et	 al.,	
2007,	 Bei	 and	Maas,	 1998,	 Bilousova	 et	 al.,	 2011);	 and	 bone	 morphogenetic	 factor	





Collections	 of	 DPSCs	 have	 been	 evaluated	 as	 potential	 subjects	 for	 iPSCs	 banks	 by	




As	hDPSCs	harbour	the	potential	 to	overcome	many	of	 the	difficulties	 that	other	SCs	
present,	 and	 as	 their	 quality	 as	 SCs	 is	 not	 hindered	 by	 difficult	 access	 or	 ethical	









contact	 with	 nutrients	 and	 signals,	 developing	 heterogeneously.	 Cells	 allocated	 into	
planar	cell	culture	flasks	become	flatter,	divide	abnormally	and	lose	their	differentiated	
phenotype	 (Baker	 and	Chen,	 2012).	 Thus,	many	 findings	 in	 2D	 static	 culture	 are	 not	
reproducible	 in	 vivo	 or	 in	 tissue	 explants.	 The	 efforts	 to	 solve	 the	 gap	 between	 the	
culture	techniques	and	the	in	vivo	tissue	have	derived	into	the	development	of	3D	static	
and	 dynamic	 culture	 systems.	 These	 try	 to	mimic	 the	 host	 tissue	microenvironment	
more	accurately.	Adding	a	scaffolding	machinery,	mechanical	stimulus	and	perfusion	of	
culture	media	through	the	cells.	Enhancing	the	exchange	of	nutrients	and	removal	of	








and	 their	 interactions.	 Herein,	 water,	 nutrients,	 cytokines	 and	 growth	 factors	 are	
delivered	to	the	cells.	To	regain	functionality	of	damaged	bone,	this	microenvironment	













allow	access	 to	bigger	molecules.	Accordingly,	we	have	 to	 consider	 its	mass	 transfer	
properties	and	the	particular	needs	of	the	cell	type.	
After	 transplanting	 the	 new	 grown	 tissue,	 osseointegration,	 osteoinduction,	






















	There	 is	 a	 wide	 range	 of	 regulatory	 approved	 biodegradable	 and	 bioresorbable	
polymers	 used	 in	 manufacturing	 scaffolds	 with	 osteoconductive	 and	 osteoinductive	
features.	These	include	natural-based	materials,	with	a	polysaccharide/protein	nature,	
such	as:	alginate,	collagen,	chitosan,	starch;	and	the	synthetics-based	materials,	such	as:	
poly(α-hydroxy	 acids)	 (PHA),	 polylactic	 acid	 (PLA),	 poliglycolide	 (PGA),	 poly(lactic	 co-
glycolic	acid)	(PLGA),	poly(ε-caprolactone)	(PCL).	These	polymers	undergo	degradation	
and	 allow	 the	 vascularization	 of	 the	 engineered	 tissue	 in	 transplants.	 Bioactive	
compounds	(as	growth	factors)	can	be	embedded	in	these	polymers	and	slowly	secreted	
along	 with	 the	 degradation	 of	 the	 polymers	 (Hutmacher,	 2000,	 Augst	 et	 al.,	 2006).	









resistible	 to	 mechanical	 stress	 than	 ceramic	 scaffolds,	 a	 desirable	 feature	 for	 3D	
bioprosessing.	 Encapsulation	 of	 cells	 can	 be	 achieved	 by	 reacting	 polymers	 with	
different	charges	and	forming	an	aqueous	biocompatible	matrix	(Uludag	et	al.,	2000).	
However,	 the	 use	 of	 highly	 toxic	 solvents	 in	 the	 polymerisation	 methods	 is	
disadvantageous	 for	 the	 encapsulated	 cells.	 As	well,	 the	 difficulties	 in	 the	 technique	
make	difficult	to	incorporate	bioactive	compounds	in	most	of	the	polymeric	scaffolds.	
Alginates	are	biopolymers	widely	utilised	in	the	industry	and	in	clinical	studies.	Alginates	
are	 found	 in	 natural	 sources	 as	 an	 heterogeneous	 population	 of	 polymers,	 they	 are	
purified	 from	 different	 species	 of	 seaweed,	 brown	 algae	 and	 bacteria	 (Augst	 et	 al.,	







Alginates	 are	 natural	 hetero-polysaccharides	 isolated	 from	 brown	 algae	 such	 as	
Laminaria	 hyperborea	 and	 lessonia.	 Alginic	 acid	 is	 constituted	 by	 an	 heterogeneous	
mixture	of	guluronic	acid	(G),	D-manuronic	acid	(M),	with	different	concentration	ratio	




(arrangement	and	 ratio	of	 the	G/M-blocks)	 as	well	 as	 the	 type	and	 concentration	of	
cations	will	produce	gels	with	different	properties.		
The	 mechanical	 properties	 of	 the	 hydrogel	 beads,	 stiffness	 and	 swelling,	 can	 be	
controlled	 by	 physical	 factors	 as	 alginate	 solution	 concentration,	G/M	 ratio,	 and	 the	
cross-linking	density	(time,	temperature	and	stirring	dependant).	Normally	the	higher	
the	concentration	of	polymer,	the	stiffer	the	gel.	However,	the	viscosity	of	the	pre-gelled	
solution	will	 be	 higher	 as	 well	 and	 the	mechanical	 stress	 produced	 by	 handling	 the	
solution	 could	 damage	 the	 cell	 content.	 Managing	 the	 elasticity	 of	 the	 beads	 and	
avoiding	 high	 levels	 of	 viscosity	 product	 of	 the	 concentration,	 can	 be	 achieved	 by	
manipulating	 the	 G/M	 ratio	 and	 by	 addition	 chelating	 agents.	 Gelling	 at	 lower	

















minimally	 invasive	 procedure.	 These	 can	 host	 different	 types	 of	 MSCs	 and	 be	
cryopreserved	maintaining	cell	viability	 for	banking	 for	 future	use	 (Venkatesan	et	al.,	


























cell	 populations	 for	bone-related	 cell	 therapeutic	products	 requires	 the	 very	difficult	
task	of	replicating	this	complex	and	specific	microenvironment	and	the	dynamicity	of	its	
transport	 characteristics.	 Thus,	 the	 design	 of	 adequate	 tailor-made	 bioprocessing	
systems	able	to	achieve	such	high	standards	is	on	demand	(Salgado	et	al.,	2004).	The	
desirable	bioprocessing	should	consider	control,	 reproducibility	and	 the	possibility	 to	
scale	up,	as	well	as	the	routine	good	manufacturing	practices	(GMP)	required	for	clinical	
applications.		
Different	 bioprocessing	 systems	 using	 shear	 stress	 have	 been	 under	 study.	 The	
mechanisms	 in	 which	 shear	 stress	 affects	 cell	 culture	 are	 not	 yet	 established.	
Nonetheless,	 it	 is	clear	that	it	 is	an	important	biophysical	signal,	with	cell	growth	and	
bone	 mechano-transduction	 effect.	 These	 mechanisms	 comprise	 calcium	 signalling,	
mechanical	 force	 transmission	 along	 fibrous	 cytoskeletal	 networks,	 cell-cell	
communication,	and	disruption	of	ligand-receptor	binding,	between	others	(Akins	et	al.,	
1997,	Morrison	et	al.,	1992,	Talbot	et	al.,	2010).		







seeded	 into	 microcarriers	 and	 the	 culture	 media	 is	 subjected	 to	 turbulence	 by	 a	
magnetic	 stirrer.	 The	 amount	 of	 shear	 stress	 depends	 on	 the	 stirrer	 speed.	 This	
bioprocessing	has	successfully	been	used	to	generate	bone	constructs.	Sikavitsas	and	
colleagues	 used	 a	 system	 consisting	 of	 murine	 MSCs	 (mMSCs),	 porous	 PLGA	 disks	





(Qian et al., 2013)
(Kleinhans et al., 2015)
BSEL in-house design






successfully	 assess	 a	mice	 in	 vivo	model	 (Jin	et	 al.,	 2014).	Nonetheless,	 the	 constant	
stirring	of	culture	media	causes	turbulent	flow	around	the	scaffolds	and	the	cells	can	




scaffolds	 (Salgado	 et	 al.,	 2004,	 Sikavitsas	 et	 al.,	 2002,	Martin	 et	 al.,	 2004).	 Another	




did	 an	 early	 study	 with	 murine	 MSC/osteosarcoma	 cells	 in	 bioceramic	 hollow	
microspheres	 (D=0.2-0.3)	 bioprocessed	 by	 RWV,	 demonstrating	 the	 production	 of	
calcium	phosphate	crystals,	with	characteristics	comparable	with	HA		(Qiu	et	al.,	1999).	
Botchwey	 et	 al.	 developed	 a	 hollow,	 lighter-than-water	microcarriers	 of	 bioerodible	






are	 enhanced	 compared	 to	 static	 culture.	 However,	 proliferation	 was	 decreased	
(Sikavitsas	et	al.,	2002).	Hwang	et	al.	studied	mMSCs	encapsulated	in	alginate	hydrogels	













and	 differentiation	 are	 hindered,	 achieving	 poor	 mineralisation	 and	 ALP	 activity	
(Venkatesan	et	al.,	2015,	Sikavitsas	et	al.,	2002).	However,	none	of	these	bioprocessing	
has	been	able	to	recapitulate	the	conditions	of	 the	microenvironment	 found	 in	bone	











supplementing	essential	 nutrients	 to	 all	 the	 cells	 in	 the	 scaffold,	while	 removing	 the	
metabolic	waste	throughout	the	cultivation	process.		
These	systems	are	supplied	with	a	peristaltic	pump	to	drive	culture	media	through	the	









dynamic	 flows.	These	results	coincide	with	 the	net	 fluid	 transport	of	 the	 fluid	profile	
(Jacobs	et	al.,	1998).	Another	report	performed	by	Sinlapabodin	and	colleagues	studied	
the	 effect	 of	 perfusion	 flow	 rate	 (1-3-5	 ml/min)	 in	 cell	 density	 and	 osteogenic	
differentiation.	They	showed	that	high	flow	rates	can	cause	the	detachment	of	cells	and	
limit	ALP	activity	and	intracellular	calcium	content.	As	well,	they	indicated	that	the	lower	
flow	 rate	 gave	better	 expansion,	 but	 less	ALP	 and	 internal	 calcium	content	 than	 the	
intermediate	flow	(Sinlapabodin	et	al.,	2016).	Accordingly,	each	bioreactor-scaffold-cell	
type	will	have	to	be	assessed	for	the	adequate	flow	rate.	Many	studies	have	been	done	
with	 steady	 flow.	 Wang	 and	 colleagues	 cultured	 murine	 osteoblasts	 seeded-β-TCP	










2014,	 Kleinhans	 et	 al.,	 2015).	 Expansion	 and	 gene	 expression	 have	 been	 shown	





parameters.	 However,	 further	 optimization,	 modification,	 or	 the	 design	 of	 new	
bioreactors,	as	well	as	the	full	understanding	of	signalling	and	the	culture	medium,	are	












required	 in	culture	medium,	 the	global	system	to	provide	the	adequate	cues	at	 local	

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































carbohydrate	 intermediates.	 But	 these	 represents	 a	 small	 proportion	 of	 the	 total	
glucose	 consumption.	 In	 vitro,	 carbohydrates	 will	 be	 provided	 in	 basal	 medium	 as	
glucose.	It	is	known	that	high	glucose	concentrations	could	be	harmful	for	certain	cell	
types	 (Jung	et	al.,	2012b).	Thus	a	 low	glucose	concentration	 is	normally	used	 in	MSC	
culture	(5.5mM).	Lactate,	a	by-product	of	glucose	metabolism,	can	reduce	growth	and	










Lipids	 that	 stimulates	 growth,	 for	 instance,	 cholesterol,	 linoleic	 acid,	 oleic	 acid	 and	
phospholipids	 are	 found	 in	 serum.	 Hence	 media	 with	 serum	 won’t	 require	












Vitamins	 primarily	 act	 as	 coenzymes	 or	 prosthetic	 groups	 supporting	 enzymatic	
functions	in	metabolic	processes.	Essential	vitamins	required	in	cell	culture	comprise	fat-
soluble	vitamins	such	as	A,	D,	E,	K,	thiamine,	riboflavin,	niacin	pyridoxine,	pantothenic	





functions.	Most	mammalians	 have	 a	 plasma	osmotic	 pressure	 of	 260-320	mOsm/kg,	
humans	in	particular,	have	a	plasma	osmotic	pressure	of	290	mOsm/kg	and	cells	grow	








that	 are	 not	 found	 in	 basal	 medium	 and	 is	 an	 extremely	 complex	 fluid.	 With	 an	
undefined	nature,	it	is	known	to	be	constituted	by	a	comprehensive	range	of	biological	
factors,	 with	 a	 balanced	 action	 in	 growth	 promotion,	 inhibition	 and	 differentiation.	
Growth	factors	found	in	serum	as	PDGF,	EGF,	IGF-1,	IGF-2	are	known	to	be	related	with	
cell	 proliferation	 and	 differentiation.	 Adhesion	 factors	 as	 fibronectin	 support	 cell	
attachment	and	expansion.	The	main	functions	of	serum	comprise	providing:	essential	






from	 animal	 origin.	 They	 pose	 numerous	 safety	 issues	 in	 clinical	 therapy,	 including	
possible	 infections	 and	 severe	 immune	 reactions.	 Additionally,	 serum	 composition	
varies	 from	 batch	 to	 batch.	 Hence,	 constant	 attempts	 have	 been	 made	 to	 develop	









































differentiation	 towards	 the	 osteogenic	 lineages	 in	 vitro.	 Additionally,	 clinical	




to	 produce	 homogenous	 osteogenic	 cells	 in	 the	 adequate	 three-dimensional	
environment	 is	 not	 easily	 achieved.	 Furthermore,	 two-dimensional	 and	 three-





especially	 into	osteoblasts,	 and	 the	development	of	 three	dimensional	 cost-effective	
bone	constructs	within	a	bioreactor	culture	system	for	clinical	applications.	Specifically,	
this	can	be	achieved	through	the	characterisation	of	hDPSCs	as	MSC-like	cells	 in	a	2D	
environment	 as	 this	 represents	 the	 starting	material	 in	 a	 three-dimensional	 culture.	
Subsequently,	 the	 focus	would	 be	 on	 the	 development	 of	 an	 integrated,	 single	 step	
culture	 process	 for	 direct	 osteogenic	 differentiation	 of	 hDPSCs	 by	 encapsulation	 in	





by	 following	 the	 minimal	 criteria	 defined	 by	 The	 International	 Society	 for	 Cellular	
Therapy	(ISCT),	with	the	examination	of	the	undifferentiated	and	proliferative	quality	of	






the	 bone	 neo-tissue	 constructs	 and	 comparison	with	 Horizontal	 Aspect	 Ratio	 Vessel	
(HARV)	 bioreactor	 and	 three-dimensional	 static	 culture.	 Ultimately,	 generating	 an	 in	
vitro	protocol	for	the	production	of	cell	populations	from	osteoblastic	lineage	with	high	
therapeutic	potential.	

















This	 study	 addressed	 the	 in	 vitro	 bone	 mimicry	 capacity	 of	 hDPSCs	 from	 donors,	
encapsulated	 in	 3D	 alginate	 beads	 and	 the	 effect	 of	 Rotating	Wall	 Vessel	 bioreactor	
coupled	with	 perfusion	 flow	of	 culture	media;	 following	 cell	 fate	 through	 the	whole	




b) Comparison	 between	 the	 in	 vitro	 osteogenic	 differentiation	 capability	 of	 hDPSCs	












• Osteogenic	 differentiation	 medium:	 maintenance	 medium	 plus	 5	 mM	 β-
glycerophosphate	(β-GP,	Sigma),	0.1	mM	dexamethasone	(Dex,	Sigma),	0.5	mM	ASAP	
(Sigma),	1.8	mM	KH2PO4	(Sigma).	
• Maintenance	 BMP-2	 medium:	 maintenance	 medium,	 plus	 300	 pg/ml	 Bone	 BMP-2	
(Peprotech).	










• Adipogenic	 differentiation	 medium:	 growth	 medium	 plus	 0.5	 mM	 3-isobutyl-1-












μm	 strainer.	 The	 extraction	 and	 isolation	 of	 the	 hDPSCs	 was	 done	 in	 Leeds	 Dental	
Institute,	in	collaboration	with	the	University	of	Leeds.	
3.1.3 hDPSCs	maintenance	

















Single-cell	 suspensions	 of	 naïve	 hDPSCs	 (<	 passage	 5)	were	 seeded	 into	 T-flasks	 in	 a	
humidified	 incubator	 set	 at	 37°C	 and	 5%	 CO2	 with	 a	 density	 of	 5x103	 cells/cm2,	





Single-cell	 suspensions	 of	 naïve	 hDPSCs	 (<	 passage	 5)	were	 seeded	 into	 T-flasks	 in	 a	
humidified	 incubator	 set	 at	 37°C	 and	 5%	 CO2	 with	 a	 density	 of	 5x103	 cells/cm2,	





Single-cell	 suspensions	 of	 naïve	 hDPSCs	 (<	 passage	 5)	were	 seeded	 into	 T-flasks	 in	 a	
humidified	 incubator	 set	 at	 37°C	 and	 5%	 CO2	 with	 a	 density	 of	 5x103	 cells/cm2,	
maintenance	medium	was	used	and	 then	 incubated	 for	3-4	days	until	achieving	80%	









a	 sterile-filtered	solution	composed	of	1.1%	 (w/v)	alginic	acid	 (Sigma)	and	0.1%	 (v/v)	
gelatin	(Sigma)	in	PBS	(pH	7.4)	as	described	in	our	previous	study	(Randle	et	al.,	2007b).	
The	 cell	 suspension	 was	 driven	 through	 a	 peristaltic	 pump	 (Model	 P-1,	 Amesham	
Biosciences,	U.K.)	 and	dropped	 from	at	 least	30	mm	height	 into	gently	 stirred	cross-
linking	 solution	 (100	 mM	 calcium	 chloride	 (CaCl2)	 and	 10	 mM	 N-(s-hydroxyethyl)	
piperazine-N-(2-ethane	sulfonic	acid)	at	pH	7.4).	The	flow	rate	of	the	pump	was	adjusted	
to	 give	 single	 droplets	 using	 a	 25-gauge	 needle	 (Becton	Dickinson,	Oxfordshire,	UK).	
Upon	 contact	 with	 the	 solution,	 gelling	 of	 the	 alginate	 droplets	 started	 and	 after	 5	
minutes	 in	 the	 solution,	 bead-shaped	gels	with	 an	 approximate	diameter	of	 1.3	mm	
were	obtained.	The	droplets	remained	in	the	solution	being	stirred	for	5	more	minutes	
at	room	temperature	to	allow	the	beads	to	set.	Finally,	the	beads	were	washed	three	
times	 in	 PBS	 and	 placed	 into	 normal	 hDPSC	 growth	 or	 differentiation	 culture	media	
(Randle	et	al.,	2007a)	as	 required	 for	 the	experiment.	To	avoid	contamination,	 tubes	





























Group	 Medium	 		 		 		 		
		 Maintenance	 Maintenance		 Maintenance		 Osteogenic		 Osteogenic		
		 		 BMP2	 Simvastatin	 BMP2	 Simvastatin	
Control	 28	 0	 0	 0	 0	
BMP2	only	 7	 14	 0	 0	 0	
Symvastatin	
only	 7	 0	 14	 0	 0	
Osteo	BMP2	 7	 0	 0	 21	 0	
Osteo	
Symvastatin	 7	 0	 0	 0	 21	
3.1.10 Fabrication	of	a	perfusion	RWV	bioreactor	vessel	
A	novel	 in-house	 designed	 computer-controlled	 RWV	bioreactor	was	 used	 in	 the	 3D	
experiments.	Which	is	able	to	deliver	continuous	oxygenation,	supply	of	nutrients,	and	
removal	of	metabolic	wastes.	The	gas	exchange	was	achieved	via	using	a	gas-permeable	





























































total	 reflectance-Fourier	 transform	 infra-red	 spectroscopy	 (ATR-FTIR).	 	 The	 human	








Intracellular	 esterase	 activity	 and	 an	 intact	 plasma	 membrane	 are	 distinguishing	
characteristics	of	 live	cells.	This	assay	discriminates	the	 live	and	dead	cells	within	the	
alginate	 hydrogels,	 by	 staining	 with	 cell	 membrane-permeant	 dye,	 3',6'-Di(O-acetyl-
2',7'-bis[N,N-bis(carboxymethyl)	 aminomethyl]	 fluorescein	 tetraacetoxymethyl	 ester	















vigorously	 for	5	minutes	 to	dissolve	 the	scaffold	and	 induce	cell	 lysis.	 From	this	 step	
onwards,	everything	was	done	in	darkness.	The	plate	was	allowed	to	incubate	at	room	






orange	 formazan	 dye.	 The	 amount	 of	 formazan	 produced	 by	 this	 reaction,	 is	
proportional	 to	 the	 living	 cell	 number.	 3	 hydrogels	 beads	were	 harvested	 (n=3)	 and	
deposited	in	96	well	plate	with	100	uL	of	media.	The	samples	were	pre-incubated	in	the	
incubator	at	37oC	and	with	5%	CO2.	10	uL	of	CCK-8	reagent	were	added	to	each	well	and	
then	 samples	 were	 incubated	 in	 the	 incubator	 for	 4	 hours.	 After,	 the	 supernatant	
absorbance	 at	 450	 nm	 was	 measured	 with	 GLoMax	 96	 microplate	 luminometer	
(Promega).	
3.1.16 Real	Time	Polymerase	Chain	Reaction	(qPCR)	
Total	 RNAs	 from	 the	 samples	 is	 extracted	 by	 using	 RNeasy	 kit	 according	 to	 the	
manufacturer’s	 instructions.	 If	 necessary	 dissolve	 the	 beads	 with	 depolymerisation	
buffer	 for	 20	minutes,	RNA	 is	 reversed	 transcribed	 into	 complementary	DNA	 (cDNA)	
using	the	Reverse	Transcription	System.	Briefly,	cocktail	for	cDNA	synthesis	consisting	of	
1	μg	of	RNA,	4	μl	of	MgCl2	(25	mM),	2	μl	of	dNTPmix	(10	mM),	2	μM	of	RT	10X	Buffer,	





10min,	 and	 then	 reverse	 transcription	 is	 performed	by	 setting	 the	program	 for	 92oC	
burst	 for	20-40	 cycles	depending	on	 the	 sample.	50	μl	 cDNA	 samples	 containing	 the	
mastermix,	5	μl	10X	PCR	Buffer	(-Mg),	1	μl	dNTP	mixture	(10	mM),	1.5μl	MgCl2	(50mM),	




Gene	 Sequence	 		 Size	 AT(oC)	
GAPDH	 Forward	Primer	 GGAGCGAGATCCCTCCAAAAT	 197	 62	
	 Reverse	Primer	 GGCTGTTGTCATACTTCTCATGG	 	
	 	 	 	 	
Runx2	 Forward	Primer	 TGGTTACTGTCATGGCGGGTA	 101	 62	
	 Reverse	Primer	 TCTCAGATCGTTGAACCTTGCTA	 	
	 	 	 	 	
Col1a1	 Forward	Primer	 GAGGGCCAAGACGAAGACATC	 140	 62	
	 Reverse	Primer	 CAGATCACGTCATCGCACAAC	 	 	
	 	 	 	 	
ALPL	 Forward	Primer	 ACCACCACGAGAGTGAACCA	 79	 62	
	 Reverse	Primer	 CGTTGTCTGAGTACCAGTCCC	 	 	
	 	 	 	 	
SOST	 Forward	Primer	 ACACAGCCTTCCGTGTAGTG	 123	 61	
	 Reverse	Primer	 GGTTCATGGTCTTGTTGTTCTCC	 	
	 	 	 	 	
BGLAP	 Forward	Primer	 CACTCCTCGCCCTATTGGC	 112	 62	









then	 blocked	 by	 incubating	 for	 10	minutes	 in	 10%	 serum	 in	 staining	 buffer.	 A	 good	











(BD	 Fortessa	 flow	 cytometer;	 BD	 biosciences/	 Guava	 easyCyte	 8HT	 benchtop	 flow	
cytometer;	Merck	Millipore).	
3.1.18 Immunocytochemical	stainning		





















by	 measuring	 ρ-nitrophenol	 phosphate	 (ρNPP)	 content.	 Three	 beads	 (n=3)	 were	









The	metabolic	activity	of	 the	cells	 is	directly	 related	 to	 the	metabolic	 stress	 they	are	
living	 and	 will	 impact	 the	 cells	 proliferation	 and	 differentiation.	 The	 concentration	





The	 paraffin	wax	 embedding	 of	 the	 hydrogels	 for	 further	 sectioning	 and	 histological	
analysis	was	done	following	the	same	procedure	for	all	experiments	as	described:	beads	
were	 fixed	 in	 the	 appropriate	 fixative	 depending	 on	 the	 sample	 point	 (see	 Table	 8),	











Ethanol	70%	 First	 2	weeks	 of	 experiment	 (first	week,	









Paraffin-embedded	 slides	 were	 deparaffinised	 and	 rehydrated,	 by	 placing	 them	 in	
paraclear	and	decreasing	concentrations	of	ethanol.	After,	the	slides	were	immersed	in	
a	40	mM	alizarin	red	S	 (Sigma-Aldrich)	solution	(pH	4.2)	 for	up	to	5	minutes	at	room	
temperature,	 checking	 for	 the	 red	 colour	 granules	 forming	 in	 the	 slides	 under	 the	





Paraffin-embedded	 slides	 were	 deparaffinised	 and	 rehydrated,	 by	 placing	 them	 in	
















immersed	 in	eosin	y	solution	(Sigma)	 for	30	seconds.	The	slides	then	were	dried	 in	a	




















and	 the	 relative	 amount	 of	 hydroxyapatite	 in	 each	 of	 the	 bead	 was	 compared	 by	
calculating	 the	 ratio	 between	 wavelength	 values	 at	 1415	 and	 1035	 [cm-1],	 both	
characteristic	 for	 the	 organic	 (mostly	 collagen	 I)	 and	 inorganic	 composition	 of	 bone	
(mostly	hydroxyapatite)	respectively.		







further	 evaporation,	 thus	 ensuring	 that	 the	 bead	 remains	 hydrated	 during	
measurements.	Images	were	acquired	with	8	cm-1	spectral	resolution	with	32	co-adding	
scans.	 A	 sample	 measurement	 would	 normally	 require	 less	 than	 1	 minute	 to	 be	
processed.	 Three	 beads	 (n=2)	 were	measured	 from	 each	 sample.	 Spectral	 data	 was	
analysed	using	the	Isys	software	(Spectral	Dimension,	Malvern,	Aus).	Factor	analysis	was	
applied	to	the	spectral	region	of	1110-990	[cm-1].	Results	were	analysed	simultaneously	
by	 concatenating	 all	 images	 together	 before	 the	 factor	 analysis.	 Allowing	 a	 direct	






on	 all	 graphs	 represent	 the	 standard	 deviation	 of	 their	 average	 values.	 Comparable	
values	 from	each	 group	were	 subjected	 to	 statistical	 analysed	with	 student	 t-test	 or	



















life	 span	 and	 differentiation	 capacity,	 present	 differences	 ranging	 from	 subtle	 to	






neural	 crest.	 Nevertheless,	 these	 cells	 share	 several	 characteristics	 with	 MSCs,	











markers	CD73	 (ecto-5’nucleotidase;	 cell-cell	 interactions,	migration	 and	modulation),	
CD90	 (Thy-1	 antigen;	 cell-cell	 interactions)	 and	 CD105	 (Endoglin;	 TGF-β	 receptor	 III)	
when	measured	by	flow	cytometry,	Other	cell	surface	marker	characteristic	of	MSCs	is	











MSCs	 are	 highly	 proliferative	 cells	 able	 to	 form	 colonies	 of	 functional	 clones	 under	
normal	culture	conditions.	These	colonies	when	grown	in	incubators	can	be	driven	to	










Undifferentiated	 hDPSCs	 can	 be	 induced	 to	 Osteogenic	 differentiation	 by	 treatment	
with	BMPs,	a	 family	of	growth	 factors	which	act	as	direct	 cues	 for	differentiation	by	
driving	a	chain	of	events	that	triggers	the	expression	of	runx2	and	causing	the	initiation	
and	propagation	of	genes	in	charge	of	the	development	and	maturation	of	osteoblasts	
(e.g.	 collagen	 I,	 osteopontin,	 alkaline	 phosphatase	 and	 osteocalcin).	 Dexamethasone	
(Dex)	 and	 simvastatin	 are	 two	 drugs	 that	 act	 as	 indirect	 differentiation	 cues,	 by	
interacting	with	 the	 BMP	pathway,	 they	 down-regulate	 the	 effect	 of	 tumor	 necrosis	
factor	(TNF-α),	a	inflammatory	mediator	with	inhibitory	effect	in	osteogenesis.	Dex	has	
been	reported	to	protect	cells	from	apoptosis	in	confluent	culture.		β-glycerol	phosphate	




stimulates	 ECM	 secretion	 (collagen	 type	 I)	 is	 a	 vital	 cofactor	 for	 enzymes	 that	
hydroxylate	proline	and	lysine	in	pro-collagen,	in	its	absence,	collagen	is	not	properly	
formed	(Pittenger	et	al.,	1999,	Langenbach	and	Handschel,	2013).	The	most	common	
medium	for	osteogenic	differentiation	was	 first	 reported	 in	1985	by	Tenenbaum	and	
Heersche,	it	uses	Dex,	β-GP	and	ASAP	in	serum	medium	and	it	has	became	the	golden	
standard	for	osteogenic	differentiation	(Tenenbaum	and	Heersche,	1985).			









signaling	 are	 typically	 used	 in	 chondrogenic	 differentiation	 mediums.	 Although	 the	
mechanism	in	which	insulin	acts	is	still	unidentified,	but	it’s	known	to	be	essential.	If	not	
included,	the	differentiation	is	not	possible	(Mueller	et	al.,	2013).		
For	 characterization	 purposes,	 chondrogenic	 differentiation	 can	 be	 confirmed	
histologically	by	the	appearance	of	proteoglycan-rich	ECM	(Pittenger	et	al.,	1999).		
4.1.3.3 Adipogenic	differentiation	of	hDPSCs	
Undifferentiated	hDPSCs	 can	be	 induced	 	 to	Adipogenic	differentiation	by	 treatment	
with	 transcription	 factors	 cyclic	adenosine	monophosphate	messenger	 (cAMP)	which	
triggers	cAMP	response	element-binding	protein	(CREB),	these	drive	the	expression	of	
CCAAT/enhancer-binding	 proteins	 (C/EBPs)	 and	 of	 transcription	 factor	 peroxisome	
proliferator	 activated	 receptor	 gamma	 (pPAR-δ)	 which	 regulates	 adipose	 tissue	
development	and	maturation	(Rosen	and	MacDougald,	2006).	The	most	common	media	
for	 Adipogenic	 differentiation	 uses	 1-methyl-3-isobutylxanthine	 (IBMX),	 Dex,	 insulin,	




important	 for	 the	 tri-lineage	 differentiation,	 and	 when	 combined	 with	 IBMX	 they	
regulate	pPAR-δ	and	C/EBPs	and	promote	adipogenesis.	





therapy,	 requires	 understanding	 the	 behaviour	 of	 cells	 under	 normal	 MSC	 culture	
conditions.	This	chapter	focus	in	the	characterisation	of	the	hDPSCs	as	MSC-like	cells	by	
studying	 the	 undifferentiated	 expansion,	 the	 passaging	 and	 the	 further	 tri-lineage	
differentiation,	as	well	as	the	nutritional	and	environmental	requirements	of	hDPSCs.	









kinetic	 and	 flow	cytometry	 characterisation,	 to	 assess	which	passage	would	allow	 to	








The	 expansion	 and	 maintenance	 of	 undifferentiated	 hDPSCs,	 while	 retaining	 their	
multipotency,	 is	 an	 important	 step	 in	 designing	 a	 bone	 tissue	bioprocessing,	 since	 it	
provides	 the	 starting	 material	 for	 the	 further	 differentiation.	 Establishing	 the	
appropriate	 passage	 that	 will	 retain	 the	 multipotent	 characteristics	 as	 well	 as	 the	
proliferation	rate	of	the	parental	cells,	meanwhile	allowing	to	suffice	the	amount	of	cells	
required,	was	the	first	step	in	this	characterisation.	




































regulated	until	 totally	disappearing	at	 the	end	of	 the	process.	As	well,	CD14/	CD11b,	
CD34,	CD45,	CD79α/	CD19	and	HLA	class	II	are	always	negative.		











Figure	 17	 Doubling	 times	 and	 live/dead	 ratios	 for	 12	 passages	 of	 undifferentiated	
hDPSCs.	For	each	group	n=3		(*:	significantly	different	compared	to	the	parent	cells,	
P<0.05)	










































The	 histograms	 and	 percentage	 of	 expression	 of	 CD73,	 CD90	 and	 CD105	 for	 every	
passage	can	be	seen	in	Figure	18	and	Figure	19	respectively.	It	is	important	to	comment	
that	histograms	for	passage	8	and	10,	appear	different,	as	the	measurements	were	done	
by	 different	 flow	 cytometer	 than	 the	 other	 samples	 (Guava	 easyCyte	 8HT	 flow	
cytometer,	Millipore).	
	
Figure	 18	 Histograms	 for	 the	 markers	 CD73,	 CD90	 and	 CD105	 measured	 by	 flow	



















































Figure	 22	 Histograms	 for	 the	 grouped	 hematopoietic	markers	 CD14,	 CD11b,	 CD34,	
CD45,	CD79α,	CD19	and	HLA	class	 II	 in	one	channel,	 in	each	histogram	the	samples	
(orange),	the	unstained	cells	(red)	and	the	isotypes	can	be	seen	(light	blue).	




A	 flow	 cytometry	 characterisation	 of	 clonal	 cells	 enduring	 long-term	 culture	 was	
performed.	 Cells	 from	 passage	 4	 were	 seeded	 with	 a	 density	 of	 ≈5000	 cells/cm2,	




HLA	 class	 II	 and	 were	 found	 to	 be	 homogeneous	 and	 indistinguishable	 from	 day	 1	





































Following	 the	 determination	 of	 the	 surface	 antigen	 expression,	 the	 morphology	 of	
undifferentiated	hDPSCs	was	followed	for	7	days	of	culture.	The	cells	attached	after	3-4	
hours	 to	 the	 flask.	 The	 cells	 grew	attached	 to	 the	plastic	 surface	of	 the	 T-flasks	 and	
started	 single-cell	 spreading	and	 then	 forming	 colonies.	 The	 cells	within	each	 colony	
were	characterised	by	the	typical	fibroblast-like	morphology	analogous	to	the	shape	and	
size	of	BM-MSCs.	The	shape	and	size	was	heterogeneous.	In	the	first	day,	cells	attached	
























Following	 the	 multipotency	 and	 growth	 kinetics	 assessment,	 in	 order	 to	 evaluate	
indirectly	 the	 proliferative	 capability	 of	 hDPSCs	 in	 2D	 static	 culture,	 the	 metabolic	








































lactate	 was	 produced,	 going	 from	 the	 initial	 concentration	 of	≈0	 [mmol/L]	 to	 11.67	
[mmol/L].	Glucose	and	lactate	kinetics	can	be	seen	in	Figure	27B.	The	oxygen	tension	in	
the	medium	slowly	decreased,	fluctuating	between	180	[mmHg]	and	150	[mmHg].	The	






Following	 the	multipotency	 and	 kinetic	 studies,	 a	 tri-lineage	 directed	 differentiation	
assay	was	performed.	To	characterise	the	differentiability	of	hDPSCs	and	to	assess	if	they	













regulation	 of	 Runx-2,	 followed	 by	 its	 subsequent	 down-regulation.	 In	 Figure	 28	 and	
Figure	29,	the	change	in	Runx2	positive	cells	can	be	seen,	and	as	expected,	it	starts	high	
and	goes	down	with	the	time-course	of	the	differentiation.		
Early	 osteogenic	 differentiation	 is	 characterised	 by	 an	 up-regulation	 of	 the	 enzyme	
alkaline	 phosphatase,	 followed	by	 a	 consequent	 down-regulation.	 Flask	 coating	with	
collagen	 and	 gelatine	 has	 been	 reported	 to	 help	 enhance	 attachment	 of	 cells	 and	
differentiation.	Flasks	were	coated	with	collagen	and	gelatine	and	the	resulting	ALPase	
activity	 after	 14	 days	 of	 culture	 was	 compared	 with	 uncoated	 flask.	 The	 enzymatic	
activity	of	ALPase	was	quantified	using	a	colorimetric	assay	and	demonstrated	that	both	






































Figure	 30	 Differentiation	 time-course	 followed	 by	 	 hDPSCs	 during	 21	 days	 of	












days	 in	 different	 coatings,	 collagen,	 gelatin	 and	uncoated.	 For	 each	 group	n=3.	No	
significant	differences	were	found.	
To	 assess	 the	 quality	 of	 the	 osteoblasts	 produced	 by	 the	 hDPSCs	 differentiated	 into	
osteoblasts,	 cells	 were	 frozen	 for	 1	 year	 and	 then	 thawed	 and	 expanded	 in	 growth	











































processes	with	 the	 aim	of	 developing	 therapeutics	 and	 applications	 for	 regenerative	
medicine	and	tissue	engineering.	However,	they	possess	limited	stemness	and	through	






For	 a	 successful	 bioprocessing	 of	 hDPSCs	 with	 medical	 purposes	 to	 be	 design,	 it	 is	
essential	 to	 be	 able	 isolate	 and	 enrich	 the	 best	 cell	 populations	 that	 would	 ensure	
	 101	
optimal	 functionality,	 cell	 viability	 and	 clinical	 effectiveness,	 capable	 to	 construct	 a	
particular	 tissue	 from	 the	 cellular	 and	 extracellular	 perspective.	 One	 of	 the	 main	
characteristics	of	MSCs	is	their	multipotent	self-renewal	and	hDPSCs	are	similar	to	other	
MSCs	 in	 aspects	 including	 shape	 and	 adherence,	 multipotence	 and	 differentiability,	
however	the	maintenance	of	the	multipotent	capabilities	and	the	differentiability	are	
unique	for	each	MSC	type.	
A	 standardised	 culture	 method	 is	 critical	 to	 understand	 and	 preserve	 the	
undifferentiated	state	of	the	cells	and	support	their	clonogenicity	during	cell	renewal	





density	of	cells	will	hinder	 their	proliferative	capabilities	as	 they	need	 the	contact	 to	
develop	and	form	colonies.	A	high	seeding	density	however,	will	hinder	proliferation	as	
well.	 In	 this	 conditions,	a	 retarded	cell	 growth	 is	produced	by	contact	 inhibition,	 the	
Notch	pathway	prepares	the	cells	for	differentiation	rather	than	for	proliferation,	cells	














Piedra	 et	 al.,	 2014),	 implying	 that	 further	 analysis	 should	 be	 realised.	 Viability	 and	
proliferation	rates	(measured	as	doubling	time	(DT)	were	assessed	and	followed	through	
12	 passages,	 revealing	 a	 viability	 always	 over	 90%	with	 its	 peak	 at	 passage	 4,	 after	
viability	 started	 slowly	 but	 steadily	 decreasing.	 The	 DT	 steadily	 increased	with	 each	

























should	 be	 used	 preferentially	 in	 therapeutics.	 Cells	 from	 further	 passage	 will	
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differentiate	 and	will	 have	 potential	 for	 neo-tissue	 formation,	 albeit	 the	 results	 will	
probably	be	heterogenic	and	with	pour	reproducibility.		
Following	the	viability	and	immunophenotypic	analysis	of	the	12	first	passages,	the	same	
scheme	was	 followed	 for	 a	 10	days	 long	 culture	without	passaging.	With	 the	aim	 to	
assess	the	effect	of	contact	inhibition	in	proliferation	and	stemness,	the	parental	cells	
were	compared	with	the	resulting	cells.	Our	results	gave	a	DT	of	2.033	days,	significantly	
higher	 than	 the	 same	 passage	 4	 cells	 sub-cultured	 which	 could	 yield	 approximately	
double	the	amount	of	cells.	Interestingly,	the	stemness	markers	showed	no	significant	



















differentiation	 won’t	 provide	 significant	 benefits,	 only	 having	 a	 repercussion	 in	
reproducibility,	 as	 one	 extra	 step	 is	 added	 to	 the	 culture.	 Coating	 has	 been	 seen	 to	




regular	expansion	medium.	These	 results	 suggest	 the	possibility	 to	 store	 frozen	neo-
tissue	for	clinical	ready-availability.	
Although	 the	adipogenic	 competence	of	hDPSCs	has	not	been	 clearly	demonstrated,	
adipogenic	differentiation	of	hDPSCs	was	confirmed	by	the	formation	of	fat	precipitates	
in	 the	 samples.	 By	 day	 7	 of	 adipogenic	 differentiation,	 adipocytes	 were	

















































Traditionally,	 cells	 have	 been	 grown	 in	 two-dimensional	 static	 monolayered	 culture	
systems,	where	cells	are	grown	attached	to	a	plastic	plane	in	their	base	and	are	exposed	
to	 culture	media	 in	 their	 upper	 face.	Within	 regular	 two-dimensional	 static	 culture,	
hDPSCs	have	been	induced	to	differentiate	 into	cells	from	the	osteoblast	 lineage	and	
many	 advances	 have	 been	 done	 in	 understanding	 mammalian	 developmental	
processes.	The	sequence	of	events	followed	by	the	cells,	is	believed	to	recapitulate	the	
in	vivo	developmental	phenomena.	However,	two-dimensional	static	culture	lacks	the	




Additionally,	 cells	 become	 flatter,	 divide	 abnormally	 and	 lose	 their	 differentiated	
phenotype	 (Baker	 and	 Chen,	 2012).	 Consequently,	 research	 outcomes	 in	 two-
dimensional	static	culture	are	not	reproducible	in	vivo	or	in	tissue	explants.		
The	efforts	to	tackle	with	the	adimensionality	of	regular	two-dimensional	culture	and	
close	 the	 gap	 between	 the	 traditional	 culture	 technique	 and	 the	 in	 vivo	 tissue	 have	
derived	 into	 the	 development	 of	 three-dimensional	 culture	 systems.	 The	
microenvironment	 of	 regular	 bone	 can	 be	 temporarily	 reproduced	within	 a	 scaffold.	







complex	 and	 specific	 histoarchitecture	 of	 bone.	 It	 also	 requires	 reproducing	 the	










Table	 2:	 Current	 studies	 about	 stem	 cell	 differentiation	 towards	 bone	 tissue	 using	
various	 bioreactors.	 Their	 findings	 delivered	 mixed	 results,	 but	 all	 agreeing	 that	
bioreactors	 and	 scaffolds	 provide	 an	 advantageous	 environment	 leading	 to	 obtain	
improved	 production	 of	 cell	 constructs.	 Alginate	 encapsulation	 has	 been	 recurrently	
studied	 as	 a	 biodegradable	 matrix	 which	 is	 adaptable	 to	 three-dimensional	 culture	
systems	for	tissue	engineering.	It	has	been	reported	that	the	jointly	use	of	gelatin	with	
alginate,	 strengthen	 the	hydrogel	 to	be	used	 in	 long	 term	culture,	 as	 alginate	alone,	
when	ionically	cross-linked,	loses	Ca2+	ions	and	could	collapse	(Basmanav	et	al.,	2008).	




adopted	 this	 technology	 to	overcome	the	 limitations	 from	using	 the	 impeller-type	of	
bioreactor.	Shear	stress	 is	an	important	biophysical	signal,	with	cell	growth	and	bone	
mechano-transduction	 effect.	 It	 is	 involved	 in	 calcium	 signalling,	 mechanical	 force	
transmission	 along	 fibrous	 cytoskeletal	 networks,	 cell-cell	 communication,	 and	
disruption	of	ligand-receptor	binding,	between	others	(Akins	et	al.,	1997,	Morrison	et	
al.,	 1992,	Talbot	et	al.,	 2010).	Example	of	units	utilising	 the	advantages	of	 low	shear	
stress,	 is	 the	 family	 of	 bioreactors	 categorised	 as	 Rotating	 Wall	 Vessel	 (RWV)	
bioreactors.	Originally	designed	by	NASA,	they	are	dynamic	systems	able	to	generate	a	






	RWV-based	 bioreactors,	 when	 working	 in	 the	 right	 setting,	 have	 shown	 to	 achieve	
enhanced	 expansion	 and	 bone	 differentiation	 (Rauh	 et	 al.,	 2011).	 However,	 none	 of	





Perfusion	 bioreactors,	 incorporate	 with	 a	 continuous	 exchange	 of	 medium.	 By	
generating	a	laminar	fluid	flow	of	culture	media	through	the	bioreactor,	mass	transport	
of	nutrients	and	oxygen	is	enhanced	as	well	as	providing	mechanical	stimuli.	A	peristaltic	





calcium	 than	 either	 oscillatory	 or	 pulsing	 flow	 (Jacobs	 et	 al.,	 1998).	 Another	 report	
studied	the	effect	of	perfusion	flow	rate	(1-3-5	ml/min).	The	findings	suggest	that	a	high	


















patterns	 (Sakdee	 et	 al.,	 2009,	 Csete,	 2005)	 and	 in	 particular,	 it	 enhances	 osteogenic	
differentiation	 (He	 et	 al.,	 2010).	 In	 vivo,	 stem	 cells	 normally	 reside	 in	 relatively	 low	




design	 aspect	 requires	 to	 be	 modified.	 Fed-batch	 operation	 lacks	 control	 of	 the	
parameters	in	culture	medium	such	as	nutrients,	metabolites,	and	oxygen.	Additionally,	
it	 accumulates	 metabolic	 waste,	 which	 can	 be	 toxic	 for	 cells	 at	 inhibitory	 level	
(Abranches	et	al.,	2007).	Moreover,	abrupt	medium	exchange	in	fed-batch	systems	can	
produce	high	stress	to	the	cells.	As	cells	grow	over	the	culture	time,	the	degree	of	stress	






Cell-constructs	manufactured	 inside	an	 inadequate	environment;	 lacking	 in	nutrients,	
oxygen	and	biosignals,	with	waste	accumulation;	tend	to	produce	poor	cell-density	and	
development,	 cell-type	heterogeneity,	 ECM-poor	 and	uneven	 spatial	 cell	 distribution	
(Ong	et	al.,	2008).	Cells	closer	to	the	surface	of	the	cell-construct	would	be	preferably	
expanded	 and	 differentiated.	 Cells	 in	 the	 cell-construct	 centre,	 would	 travel	 to	 the	
surface	 to	 fulfil	 their	 nutritional	 requirements.	 Ultimately,	 when	 the	 surface	 is	











Figure	 33	 Fed-batch	 vs	 perfusion	 feeding	 strategy.	 It	 can	 be	 seen	 how	 nutrient	
















Our	 group	 has	 previously	 developed	 a	 simplified,	 integrated,	 and	 reproducible	
bioprocess	 for	 three-dimensional	 osteogenesis	 from	 ESCs	 using	 encapsulation	 with	
alginate/gelatin	 hydrogel	 and	 an	 in-house	 developed	 perfusion-RWV	bioreactor	with	
promising	results	for	therapeutic	uses	(Cha,	2010,	Yeo,	2012,	Randle	et	al.,	2007a).	In	
the	 next	 subsection,	 the	 principia	 behind	 the	 development	 of	 this	 bioprocessing	 are	
summarised.		
5.1.1 Principia	behind	the	design	of	a	perfused	bioreactor	












The	 flux	 travels	 from	high	 concentration	 regions	 to	 low	concentration	 regions	and	 is	
proportional	to	the	concentration	gradient	(spatial	derivative).	In	one	dimension:	
𝐽 = −𝐷 𝜕𝐶𝜕𝑥 	
Fick's	second	law,	derived	from	the	first	law	by	combining	with	a	mass	balance	to	the	

















the	 conceptual	 design	 of	 the	 vessel	 can	 be	 seen.	 In	 the	 resulting	 equation,	 oxygen	


















Oxygen diffusion (C) 
at tim (t)
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Figure	 34	 Solution	 of	 Fick’s	 second	 law	 and	 conceptual	 design	 of	 culture	 vessel	
(modified	from	(Cha,	2010)).	






as	 1.5	 cm	 with	 allowing	 3	 days	 of	 the	 oxygen-saturation	 time.	 This	 length	 also	
corresponds	 to	 the	 depth	 of	 a	 55-ml	 High	 Aspect	 Ratio	 Vessel	 (HARV),	 which	 was	
designed	 to	have	 sufficient	 gas-exchange	 through	 the	membrane	on	 the	back	of	 the	







A	 gas-permeable	membrane	 is	 rolled	 and	 tightly	 fixed	 to	 the	 frame	 of	 the	 vessel,	
allowing	gas-exchange	through	the	wide	surface	area	as	determined	previously.	The	
membrane	 is	 made	 of	 a	 silicon	 material	 coated	 in	 one	 side	 with	
polytetrafluoroethylene	(PTFE,	Teflon),	to	prevent	fouling	by	numerous	bio-molecules	
!"#" = %('() − +(,) ' = 1.5 + + ) = , + 0.2 !"#" = %( 3' − 2.25 ) + 0.2 + − 1.5 ( = 555, 3' − 2.25 ) + 0.2r( = 17.51 if	r	 = 	1	cm	 ⟹ 	R	 = 	2.5	cm	 ⟹ 5.25L	 = 	17.31 L ≈ 3.5	cm l ≈ 3.3	cm Volume ≈ 60	ml 
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present	 in	 culture	medium	 or	 secreted	 by	 cells.	 The	 detailed	 specifications	 of	 the	
membrane	can	be	found	in	Table	5	and	Table	6.	
Table	 5:	 Specifications	 of	 gas	 permeable	membranes,	 in	 the	materials	 and	methods	
section.	
In	 addition	 to	 the	 oxygen	 provided	 through	 the	 membrane,	 the	 culture	 medium	
perfused	 to	 the	 culture	 vessel	 comes	 oxygen-saturated	 by	 the	 use	 of	 an	 external	
oxygenator.	See	figure		
	





a	 wall	 thickness	 of	 0.5	 mm.	 The	 length	 of	 the	 tubing	 of	 approximately	 3.4	 m	 was	
designed	 to	 be	 long	 enough	 to	 saturate	 the	 culture	medium	with	 oxygen	whilst	 the	
medium	 passes	 through	 the	 oxygenator.	 The	 calculations	 were	 done	 following	 the	




design	 was	 followed.	 To	 describe	 the	 dynamic	 mass	 transfer	 of	 oxygen	 from	 bulk	
solution	into	the	alginate	spheres,	the	transfer	of	the	oxygen	along	the	media	and	the	
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transfer	 from	 the	 medium	 to	 the	 solid	 and	 the	 consumption	 of	 oxygen	 by	 the	














Boundary	conditions:	 				𝐵. 𝐶. 1: 𝐶345678 = 0	𝑎𝑡	𝑡 = 0	𝐵. 𝐶. 2:	𝐶345678 = 𝐶	𝑎𝑡	𝑧 = 0	𝐵. 𝐶. 3:	𝐶345678 = 0	𝑎𝑡	𝑧 = 𝑅	
Where	R	is	the	radius	of	the	alginate	spheres.	
𝐶345678𝐶 = 𝑒𝑟𝑓𝑐 𝑧 4 ∙ 𝐷9 ∙ 𝑡 R2 , 𝐷9 = 1.4𝑥105# 𝑐𝑚2 𝑠	𝑎𝑡	37°𝐶	






it	was	 found	 that	 for	 a	 distance	 z	 =	 1.3	mm	 to	 be	 80%	 saturated,	 approximately	 40	








Diameter	 70%	 80%	 90%	
0,5	mm	 3	min	 5	min	 23	min	
1,0	mm	 10	min	 23	min	 93	min	
1,3	mm	 17	min	 40	min	 158	min	
1,5	mm	 23	min	 52	min	 210	min	
2,0	mm	 40	min	 93	min	 370	min	
2,5	mm	 64	min	 145	min	 585	min	
	















displays	 CFD	models	 of	 oxygen	 concentration	 distributes	 in	 the	 culture	 vessel,	 the	
model	describes	the	time	required	for	medium	inside	the	vessel	to	achieve	saturation	
(Yeo,	2012).		





The	 performance	 of	 the	 in-house	 designed	 perfusion-RWV	 bioreactor,	 has	 been	
compared	with	traditional	 two-dimensional	culture	 for	 the	expansion	and	osteogenic	
differentiation	of	ESCs.	Results	demonstrate	enhanced	undifferentiated	expansion,	as	


















a	 perfusion-RWV	 bioreactor	 for	 the	 undifferentiated	 expansion	 of	 hDPSCs.	 2)	 to	





under	 normal	 culture	 conditions	 and	 that	 passage	 4	 cells	 are	 able	 to	 produce	 the	
required	number	of	cells	for	3D	culture	without	significant	differences	from	the	paternal	














to	 proliferate	 in	 suspended	 culture,	 by	 the	 presence	 of	 a	 consistent	 set	 of	 marker	
proteins	on	 their	 surface	 and	proliferative	 capabilities.	 Perfusion	was	 set	 as	 1	 vessel	
volume	per	day	(55	ml/day	medium).	
For	 the	 osteogenic	 differentiation,	 donor	 samples	 of	 hDPSCs	 were	 expanded	











AM/	 ethidium	 homodimer,	 measurement	 of	 ATP	 content	 and	 MTS	 assay,	
characterisation	 of	 mineralised	 bone	 nodules	 by	 alizarin	 red	 and	 von	 Kossa,	 H&E,	














































































































































differentiation	 processes	 to	 start	 from	 the	 same	 conditions.	 However,	 since	 we	 are	





best	 bioprocess	 for	 3D	 osteogenic	 differentiation	 was	 established	 by	 measuring	

































During	 the	 differentiation	 process,	 the	 morphology	 changes	 of	 the	 hydrogels	 were	
followed	by	light	microscopy.	By	day	7	(expansion	and	acclimatising	period),	cells	were	
likely	 to	 show	 single	 cell	 suspension	 well	 distributed	 through	 the	 hydrogel.	 The	
hydrogels	did	not	show	signal	of	mineralisation.	By	day	21	(day	14	of	differentiation),	
mineralisation	started	conquering	the	hydrogels,	and	light	almost	could	not	travel	across	
the	 hydrogels.	 By	 day	 28	 pictures	 showed	 black	 spheres,	 as	 light	 did	 not	 cross	 the	




The	 growth	 kinetics	 of	 hDPSCs	 seeded	 in	 beads	 (n=6)	 showed	 that	 by	 day	 21,	 the	




of	 the	 beads	 or	 an	 enzymatic	 change	 related	with	 differentiation,	 did	 not	 allow	 the	
reaction	buffer	to	act	on	the	cells	causing	the	down	expression	of	the	MTS	assay.	Cells	
were	 shown	 to	 be	 alive	 and	 healthy	 by	 the	 end	 of	 the	 culture	 by	 Live/	 dead	 assay,	































































For	 the	Perfusion-RWV	bioreactor,	medium	perfusion	was	 set	 to	 the	equivalent	of	 1	
vessel	volume	a	day	(55	ml	of	medium).	For	the	HARV	bioreactor	and	3D	static	culture,	
media	was	exchanged	daily	with	volumes	of	55	and	25	ml	 respectively.	Medium	was	





et	 al.,	 2007).	 In	 the	 perfusion-RWV	 bioreactor,	 glucose	 was	 consumed	 from	 ≈7.1	
[mmol/L]	to	≈6	[mmol/L].	However,	as	lactate	accumulation	was	too	low,	it	did	not	reach	
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and	 as	 glutamine	 is	 lysed	 into	 glutamate	 to	 produce	 ATP,	 it	 releases	 1	molecule	 of	
ammonia,	if	ammonia	concentration	reaches	4	[mmol/L],	it	can	have	a	toxic	effect	for	
the	 cells	 (Chaudhry	 et	 al.,	 2009).	 For	 the	 perfusion-RWV	 bioreactor,	 glutamine	
fluctuated	from	≈4	[mmol/L]	and		≈3	[mmol/L]	and	ammonia	followed	a	similar	trend,	
fluctuating	 between	 	 ≈0.78	 [mmol/L]	 and	 	 ≈1.1	 [mmol/L].	 Glutamine	 and	 ammonia	
kinetics	 for	 the	 perfusion	 RWV-bioreactor	 can	 be	 seen	 in	 Figure	50B.	 For	 the	 HARV	
bioreactor,	glutamine	fluctuated	from	≈4	[mmol/L]	and		≈2.8	[mmol/L]	and	ammonia	
followed	 a	 similar	 trend,	 fluctuating	 between	 	 ≈0.9	 [mmol/L]	 and	 	 ≈1.1	 [mmol/L].	
Glutamine	and	ammonia	kinetics	for	the	HARV	bioreactor	can	be	seen	in	Figure	51B.	For	
the	3D	static	culture,	glutamine	fluctuated	from	≈4.1	[mmol/L]	and		≈2.39	[mmol/L]	and	




fluctuating	 between	 160	 [mmHg]	 and	 140	 [mmHg].	 The	 oxygen	 kinetics	 for	 the	
















would	 reflect	 it	 and	 by	 the	 end	 of	 culture,	 5	 times	more	 cells	 would	 be	 consuming	
medium,	oxygen	and	producing	waste.	Lactate	and	ammonia	wouldn´t	reach	harmful	
levels,	they	are	limited	by	the	glucose	and	glutamate	concentration.	Nevertheless,	pH,	
glucose,	 glutamate	 and	 oxygen	 concentrations	 could	 reach	 low	 levels,	 and	 have	 a	
negative	repercussion	on	the	culture	quality.	
	


























































































Figure	 51	 Change	 with	 culture	 time	 of	 key	 substrates	 and	 metabolites	 in	 culture	
medium	 for	 the	 HARV	 bioreactor.	 A)	 Consumption	 of	 glucose	 and	 production	 of	















































































































































































in	 3D	 culture	 systems	 using	 alginate	 beads	 and	 any	 of	 the	 three	 bioprocesses	 being	
compared.	 In	 order	 to	 confirm	whether	 these	 tissues	were	mineralised	 bone	 tissue,	
histological	analysis	and	immunostaining	was	done	to	characterize	the	morphology	and	
calcium	deposits	in	tissues.		
The	 resulting	hydrogels	 from	 the	3	bioprocesses	were	 cut	 in	 slices	 and	histologically	
examined	 by	 hematoxylin	 and	 eosin	 staining	 (H&E).	 As	 shown	 in	 Figure	 53,	 samples	
displayed	 a	 heterogeneous	 morphology	 and	 behave	 different.	 However,	 the	 three	






same	 reduction.	 As	 time	 passed	 by,	 size	 and	 shape	 of	 cells,	 together	 with	 their	
surroundings	 changed,	 ECM	 was	 formed	 and	 approximately-round	 lacunae	 started	
showing	 around	 single	 cells,	 which	 is	 signal	 of	 cells	 differentiation	 into	 osteogenic	





the	 static	 culture.	 By	 day	 21	 poor	 lacunae	 formation	was	 observed,	 suggesting	 poor	
maturation	of	the	cells.	Additionally,	there	were	not	many	cells	visible	in	the	hydrogels.	
The	 perfusion-RWV	 bioreactor	 showed	 the	 production	 of	 more	mature	morphology	
than	 the	other	bioprocesses.	By	day	21,	 cells	 fully	populated	 the	 scaffold	 and	 round	
lacunae	was	formed	in	all	the	beads	except	from	the	most	inner	area	of	the	beads.	By	
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day	 28	 elongated	 lacunae	 can	 be	 seen	 in	 the	 most	 external	 area	 of	 the	 beads.	
Nonetheless,	the	inner	area	was	not	as	maturated,	showing	heterogeneity	of	the	cell	











these	 cells	 left	 the	 scaffold	 as	 consequence	 of	 mass	 transport	 limitations.	 Scale	
bar=200	µm.		
Calcified	 deposition	 was	 widely	 spread	 in	 the	 osteogenic	 beads	 and	 was	 shown	 by	
alizarin	red	s	staining	(ARS)	and	von	Kossa	staining.	ARS	results	displayed	an	increase	of	





bioreactor	 for	 days	 14	 and	 28	 of	 culture,	 additional	 pictures	 can	 be	 found	 in	 the	
appendix.	
Von	 Kossa	 staining	 was	 done	 for	 day	 28	 and	 albeit	 the	 results	 do	 not	 show	 mass	





















Figure	 57	 Fluorochrome	 labelling	 of	 bone	 constructs	 for	 Osteocalcin	 of	 beads	
differentiated	after	28	days	of	 cultureof	A)HARV	bioreactor	B)	3D	 static	 culture,	C)	
perfusion-RWV	bioreactor	and	D)	negative	control.	Scale	bar=200	µm.	
5.4.2.3 Quantitative	analysis	of	hDPSCs	3D	osteogenic	bioprocesses	
The	 quantitative	 comparisons	 among	 the	 bioprocesses	 were	 undertaken	 by	 ALPase	










difference	 in	 the	 increase	experienced	by	 the	2	bioreactors.	After	14	days	of	 culture	


























































Spectra	 from	 ATR-FTIR	 and	 X-ray	 microanalysis,	 confirmed	 that	 the	 comparison	 of	
mineralisation	in	this	study	was	based	on	the	true	calcified	hydroxyapatite	components	
(Figure	60,	Figure	61,	Figure	65,	Figure	65	and	Figure	65).	They	were	characterised	in	







the	 same	orders	of	magnitude	as	 the	perfusion-RVW	bioreactor	and	higher	 than	 the	
resulting	 from	 the	 HARV	 bioreactor,	 the	 measurements	 in	 ATR-FTIR	 were	 opposite,	
scoring	lower	than	HRV	bioreactor.		
	





Figure	61	ATR-FTIR	 spectra	 comparison	 for	 the	 three	bioprocesses	after	28	days	of	
culture	
	
Figure	 62	 ATR-FTIR	 spectra	 normal	 human	 bone	 tissue,	 obtained	 by	 Beasley	 et	 al.		






















































































































































mineralised	 deposits.	 These	 nodules	 were	 mainly	 composed	 of	 calcium	 and	
phosphorous	(proved	by	X-ray	microanalysis).	By	day	28	the	lacunae	were	distributed	in	




with	 H&E	 pictures).	 The	morphology	 of	 the	 bone	 constructs	 produced	 by	 the	 HARV	
bioreactor	can	be	seen	in	Figure	67	D	to	F,	where	cell	heterogeneity	and	less	mature	












(Zhao	 et	 al.,	 2011,	 Karbanova	 et	 al.,	 2010,	 Jensen	 et	 al.,	 2015,	 Heng	 et	 al.,	 2015).	
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Additionally,	 In	 the	 last	 years,	 there	have	been	numerous	 research	 to	develop	 three	
dimensional	 in	 vitro	 bone	 neo-tissue	 constructs	 using	 MSCs,	 3D	 scaffolds,	 growth	
factors/chemical	 cues	 and	 bioreactors,	 showing	 the	 potential	 use	 of	 MSCs	 in	 bone	
regeneration	(Sikavitsas	et	al.,	2002,	Stiehler	et	al.,	2009,	Hwang	et	al.,	2008,	Hwang	et	
al.,	 2009,	Randle	et	al.,	 2007b,	Diederichs	et	al.,	 2009,	 Jung	et	al.,	 2012a)	 .	All	 these	
studies	had	in	common	the	use	of	encapsulated	cells	(or	cells	seeded	into	a	scaffold),	a	
semi-batch	 feeding	 strategy	 and	 shear	 stress	 modulation,	 showing	 successful	
approaches	 for	 osteogenic	 differentiation	 of	 MSCs.	 Nonetheless,	 these	 efforts	 have	













by	 3D	 static	 culture.	 Pictures	 D	 to	 F	 display	 cell	 constructs	 produced	 by	 HARV	
bioprocessing.	Pictures	G	to	L	display	pictures	of	cell	constructs	produced	by	perfusion-
RWV	bioprocessing.	




platforms	 and	 the	 in	 vivo	 natural	 environment.	 Therefore,	 we	 developed	 a	 culture	
system	to	create	three-dimensional	bone-like	tissues	based	on	hDPSCs,	alginate/gelatin	
bead,	and	perfusion-RWV	bioreactor.	To	the	best	of	our	knowledge,	this	is	the	first	study	
demonstrating	 the	 three	 dimensional	 bone-like	 tissue	 formation	 from	 hDPSCs	 in	
	 145	




suspension	 environment	 within	 vessels	 of	 perfusion-RWV	 bioreactor,	 whereas	 the	
bioreactor	maintains	controlled	in	vitro	culture	conditions	that	permit	tissue	growth	and	
development.	
This	 in-house	 designed	 perfusion-RWV	 bioreactor	 produce	 a	 suspension	 culture	 by	
providing	laminar	flow	of	culture	media	and	rotation	of	the	vessel.	Hence	minimising	cell	
exposure	 to	 shear	 and	 turbulence	 which	 can	 be	 detrimental	 for	 cell	 growth	 and	
differentiation,	while	providing	sufficient	nutrients	and	oxygenation	to	support	3D	neo-
tissue	 growth	 and	 removing	 the	 undesirable	 cellular	 by-products.	 In	 our	 study,	 a	
protocol	 for	 cell	 expansion	 previously	 defined	 by	 our	 group	 for	mESCs	 was	 used	 to	
expand	undifferentiated	cells	in	3D	environment.	However,	the	need	to	design	a	specific	
expansion	 protocol	 for	 hDPSCs,	 considering	 seeding	 density,	 culture	 time	 and	 a	








and	 express	 almost	 identical	MSC	markers,	 but	 their	 differentiation	 capabilities	may	
differ.	 Interestingly,	CD105-	MSCs	were	found	to	be	more	prone	to	differentiate	 into	
osteoblastic	and	adipocytic	 lineages	and	suppressed	 the	proliferation	of	CD4+	T	cells	
(less	 immune	 response)	 more	 efficiently	 compared	 to	 the	 CD105+	 subpopulations	
(Anderson	 et	 al.,	 2013).	 If	 we	 consider	 ALPase	 activity	 as	 a	 measurement	 of	















that	 the	 stress	 produced	by	nutrients	 exhaustion	 and	metabolites	 accumulation	was	
limited	 with	 perfusion	 of	 pre-oxygenated	 fresh	 media.	 With	 a	 positive	 influence	 in	
proliferation	of	hDPSCs.	
In	 the	 comparison	 study	 between	 the	 differentiation	 capability	 of	 perfusion-RWV	
bioreactor,	HARV	bioreactor	and	3D	static	culture	of	hDPSCs	within	alginate	beads,	the	
perfusion-RWV	bioreactor	 demonstrated	much	 higher	 cell	 proliferation	 and	 viability.	
The	differences	found	between	the	systems,	may	have	their	roots	in	the	mass	transfer	








for	 their	 long-term	 growth	 and	 differentiation.	 In	 a	 static	 culture	 the	 only	 transport	
mechanism	 of	 nutrients	 is	 molecular	 diffusion,	 which	 cannot	 achieve	 the	 metabolic	
requirement	 of	 hDPSCs,	 while	 in	 both	 bioreactors,	 the	 low	 physiological	 fluid	 shear	
conditions	 enhance	 nutrient	 transport,	 thereby	 decreasing	 the	 existing	 nutrient	
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concentration	gradients	(Sikavitsas	et	al.,	2002,	Mueller	et	al.,	1999).	In	case	of	the	HARV	





distinct	 phases:	 1)	 High	 proliferation	 and	 development	 of	 extracellular	 collagenous	
matrix	(10	to	12	days).	2)	Matrix	maturation,	down-regulation	of	proliferation	and	up-








populated	of	 living	 cells,	which	 suggests	 that	 the	down	expression	of	 the	MTS	assay	
could	be	result	of	the	mentioned	decrease	in	proliferation	and	enzymatic	activity.	








It	 has	 been	 reported	 that	 the	 profile	 of	 pH	 and	 these	 metabolites	 can	 be	 used	 to	
modulate	 cell	 metabolism,	 for	 instance	 ECM	 deposition	 and	 neo-tissue	 progress	 for	










had	 similar	 profiles,	 a	 slow	 but	 steady	 decrease	 through	 the	 culture,	 implying	 the	








levels,	 this	 reflects	 the	 slow	but	 steady	 glucose	 consumption	 seen.	 3D	 static	 culture	
accumulated	 lactate	 fast,	 reaching	 a	maximum	of	 12	 [mmol/L],	 this	was	 the	 limiting	
concentration	achievable,	as	all	glucose	was	consumed.	A	high	glucose	medium	could	





consumption	of	glutamine	 reflects	 the	amount	of	 cells	 sampled	 rather	 than	 the	cells	
consumption.	Ammonia	did	not	 reach	 toxic	 levels	 through	 the	whole	 culture	 for	 the	
three	 bioprocesses,	 with	 values	 between	 1	 and	 2	 [mmol/L]	 (less	 than	 4	 [mmol/L]	
(Chaudhry	 et	 al.,	 2009)).	 Additionally,	 pH	 and	 oxygen	 concentration	 are	 other	
parameters	 to	 consider	 as	 these	 affect	 cell	 viability,	 growth,	 differentiation	 and	
metabolic	activity.	pH	in	osteogenic	medium	decreased	with	culture	time	and	followed	
the	 increase	 of	 lactate	 and	 ammonia	 concentration,	 as	 it	 is	 known	 that	 these	
metabolites	 affect	medium	 pH	 (Barngrover	 et	 al.,	 1985).	 pH	 change	 was	 within	 the	
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proper	pH	 range	 (7.0-7.4)	 of	 cell	 culture	media,	 implying	no	 strong	 influence	on	 cell	
growth	and	function.	Oxygen	has	a	major	role	in	SCs	growth	and	differentiation,	hypoxic	






showed	 most	 cells	 appear	 scattered	 in	 the	 bead	 without	 having	 form	 extracellular	
matrix.	 After,	 displayed	 well	 distributed	 tissue	 growth	 for	 both	 bioreactors	 and	
heterogeneity	 for	 the	 static	 culture.	 Morphogenesis	 of	 the	 osteogenic	 cells	 until	
achieving	maturation,	can	be	seen	in	both	the	perfusion	and	the	static	culture	by	the	








probable	 reason	behind	 the	 low	MTS	and	ALPase	activity	achieved	at	 the	end	of	 the	








the	 hDPSCs	 can	 be	 perceived	 in	 different	 levels	 for	 the	 three	 bioprocesses,	 the	
perfusion-RWV	 bioreactor	 showed	 higher	 neo-tissue	 maturation,	 seen	 by	 the	 many	
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hydroxyapatite	crystals	 found,	 the	osteocyte	 lacunae	and	the	presence	of	osteocytes	
with	 developed	 canaliculi.	 Static	 culture	 showed	 more	 maturation	 than	 the	 HARV	
bioreactor.	However	most	of	the	quantitative	analysis	suggests	that	this	maturation	is	





of	 the	 inorganic	 fraction	 (hydroxyapatite),	 and	 the	 ratio	 of	 organic	 and	 inorganic	
component,	 C/P	 is	 characteristic	 biogenic	 signature	 for	 human	 bone.	 However,	 it	 is	
recommended	 to	 use	 the	 phosphate	 peak	 of	 1035	 and	 carbonate	 peak	 of	 1415	 to	
calculate	C/P	ratio.	When	these	wavenumbers	are	used,	the	human	bone	C/P	ratio	is	








biogenic	 signature	 of	 the	 inorganic	 fraction	 of	 bone	 (hydroxyapatite).	 Pure	
hydroxyapatite	has	a	Ca/P	ratio	of	1.67	(Medina	Ledo	et	al.,	2008).	In	our	experiments	it	
can	be	seen	how	values	increase	with	time.	All	the	samples	start	in	a	virtually	null	value,	
after	 28	 days	 of	 culture,	 perfusion	 reaches	 1.23,	 static	 culture	 1.14	 and	 HARV	 0.77.	
Although,	 all	 bioprocesses	 produced	 calcium	 deficient	 hydroxyapatite	 (non-
stoichiometric),	the	increase	is	clear	and	more	research	should	be	done	until	the	proper	
ratio	is	reached.	
3D	 osteogenesis	 was	 characterised	 at	 a	 genetic	 level,	 examining	 the	 expression	 of	




activity	 of	 several	 genes	 and	 signals	 (extracellular	 and	 intracellular).	 Runx2	 is	 a	
transcription	 factor	 and	 the	 central	 control	 of	 osteogenic	 differentiation.	 Its	
upregulation	 happens	 early	 in	 the	 ontogenesis,	 and	 is	 believed	 to	 have	 a	 constant	





upregulation	 is	 characteristic	 of	 osteogenic	differentiation	 and	 can	be	 considered	an	
early	marker	of	differentiation.	Osteocalcin	(BGLAP),	is	an	osteoblast	specific	gene	and	
one	of	the	most	abundant	proteins	in	bone,	its	expression	is	significantly	upregulated	in	
matrix	 synthesis	 and	mineralisation	 (Ryoo	et	 al.,	 1997).	 Sclerostin	 (SOST)	 is	 a	 known	
specific	gene	for	mature	osteocytes,	and	It	is	integral	to	osteocyte	function	as	a	signal	










week	 of	 culture	 could	 represent	 the	 further	 transition	 from	 mature	 osteoblasts	 to	
osteocytes.	During	all	this	period,	Col1a1	and	ALPL	were	active	and	positive.	These	genes	
are	 related	 with	 ECM	 formation	 and	 mineralisation,	 and	 are	 indicative	 of	 a	 well	
developed	in	vitro	osteogenesis.	These	results	suggest	that	a	homogeneous	population	
of	cells	was	produced	with	cells	in	the	last	stages	of	maturation.	HARV	culture	showed	







osteogenesis.	 These	 results	 suggest	 that	 a	 heterogeneous	 population	 of	 cells	 was	





differentiated	 to	 osteocytes.	 During	 all	 this	 period,	 col1a1	 and	 ALPL	 are	 active	 and	




Perfusion	 bioreactor	 showed	 a	 higher	 proliferation,	 calcification	 and	 a	 more	
homogeneous	 bone	 tissue,	 the	 HARV	 bioreactor	 showed	 a	 lower	 differentiation	 in	
comparison	 with	 the	 perfusion	 system	 and	 the	 static	 culture	 showed	 good	
differentiation	 in	 the	 surface	 of	 the	 constructs,	 but	 poor	 in	 the	 inner	 part	 of	 the	
hydrogels,	additionally,	cells	left	the	construct	to	start	growing	on	the	flask	surface.	
Low	proliferation	of	cells	in	HARV	culture	(compared	with	perfusion	culture)	could	have	




















of	 3D	 bone-like	 constructs	 for	 clinical	 purposes.	 Progressive	 differentiation	 was	
































dimensional	 osteoconductive	 scaffold	 materials	 and	 bioreactor	 vessels,	 has	 been	
extensively	 working	 in	 producing	 the	 homogeneous,	 reproducible	 and	 functional	
artefact,	 required	 to	 fulfil	 this	 clinical	need	 (Gaspar	et	al.,	2012,	Godara	et	al.,	2008,	
Hidalgo-Bastida	et	al.,	2012,	Qiu	et	al.,	1999,	Zhang	et	al.,	2009,	Grayson	et	al.,	2011,	
Yeatts	 and	 Fisher,	 2011,	 Salter	 et	 al.,	 2012).	 Cells	 provide	 the	machinery	 to	produce	





transfer	 for	 cell	 nutrition.	Bioreactors	provide	 the	means	 to	deliver/	 fulfil	 nutritional	
requirements	 of	 the	 cells,	 by	 enhancing	 transport	 properties	 inside	 and	 outside	 the	
scaffold,	while	removing	the	cellular	waste.	A	variety	of	dynamic	3D	bioreactor	concepts	
mimicking	 the	 native	microenvironment	 in	 bone	 tissue,	 for	 example,	 spinner	 flasks,	
rotating	wall	vessel	constructs,	perfusion	bioreactors,	and	systems	based	on	mechanical	
or	electromagnetic	stimulation	of	cell/scaffold	composites,	have	been	developed	(Rauh	
et	 al.,	 2011).	 These	 novel	 setting,	 in	 different	 levels	 being	 successful	 in	 reproducing	
specific	aspects	of	the	in	vivo	milieu,	and	producing	mineralised	constructs,	with	positive	
expression	 of	 osteogenic	 genes	 and	 proteins,	 whilst	 partially	 mimicking	 bone	
microstructure.	Additionally,	bioreactors	allow	automation	and	make	up	for	limitations	
of	 the	 conventional	 cell	 handling	manual	 and	 static	 technique	 (Wendt	 et	 al.,	 2009).	
However,	 these	 setup	 alone	 produces	 heterogeneous	 constructs,	 with	 mixture	 of	





The	 engineering	 parameters	 occurring	 and	 controlled	 in	 bioreactors	 are	 equally	
important	 as	 the	 biological	 parameters	 associated	 with	 differentiation.	 Hence,	 the	
adequate	 cues/	 signalling	 for	 bone	 differentiation	 drive	 are	 required	 to	 be	 studied	
together	with	the	3D	bioprocessing.	The	bone	morphogenetic	proteins	(BMPs)	signalling	
pathway	 has	 widely	 been	 recognized	 as	 the	 main	 player	 in	 bone	 developmental	
processes,	and	exhibit	versatile	and	efficacious	 regulatory	 functions	 in	 the	body.	The	
disruption	of	them	has	been	connected	to	a	number	of	bone	diseases	(Chen	et	al.,	2012),	




and	 subsequently	 the	 expression	 of	 	 Osterix	 (OSX)	 in	 late	 state	 osteogenesis	
(osteoblasts)		(Wozney,	2002,	Chen	et	al.,	2004,	Bei	and	Maas,	1998).	
The	BMPs	 family	 is	a	secreted	cytokine/	growth	 factor	subfamily	of	 the	transforming	
growth	factor-β	(TGF-β)	superfamily.	They	are	multifunctional	cytokines	regulators	of	
development,	 proliferation,	 differentiation,	 adhesion	 and	 apoptosis	 in	 different	 cell	
types	at	embryonic	and	adult	ages	(Kirkbride	et	al.,	2008,	Miyazono,	2000).		
BMP2	 has	 been	 approved	 by	 the	 US	 Food	 and	 Drug	 Administration	 (FDA)	 and	 the	
European	Medicines	Agency	(EMEA)	for	the	use	in	certain	types	of	bone	fracture,	making	





















Langenfeld,	 2004).	 The	 harmful	 effect	 produced	 by	 BMPs	 may	 be	 dose	 dependant	
(DeVine	 et	 al.,	 2012).	 Hence,	 BMPs	 based	 cell	 therapeutics,	 are	 required	 to	 utilise	
minimal	dose	possible.	In	addition	to	the	side	effects,	the	use	and	costs	of	rhBMPs	are	
also	 to	 be	 considered.	 BMPs	 are	 delicate	 to	 handle,	 expensive	 to	 manufacture	 and	
supra-physiological	 doses	 are	 used,	 resulting	 in	 high	 costs.	 The	physiological	 level	 of	
BMP2	 in	humans	 is	of	≈300	[pg/ml]	 (Tosovsky	et	al.,	2014).	Nonetheless,	 in	standard	
conditions	of	culture	and	in	clinical	applications,	the	concentrations	utilised,	range	from	





A	 less	 direct	mechanism,	 is	 followed	 by	 statins.	 Statins	 are	 inhibitors	 of	 cholesterol	
synthesis.	 However,	 they	 have	 been	 demonstrated	 to	 have	 cholesterol-independent	
anabolic	effects	on	bone	metabolism	and	fracture	healing	(Pagkalos	et	al.,	2010b).	By	
interacting	 with	 both	 canonical	 and	 non	 canonical	 BMP	 pathways,	 they	 upregulate	
BMP2	expression,	along	with	the	cascade	of	genes	associated	with	BMP2	(Chen	et	al.,	
2010).	 Several	 inexpensive	 statins	 are	 available	 with	 different	 molecular	 and	


















of	 human	 plasma	 (≈300	 [pg/ml])	 (Tosovsky	 et	 al.,	 2014).	 In	 this	 study,	 the	 effect	 of	
supplementing	 with	 BMP2	 at	 physiological	 level	 the	 designed	 bioprocessing,	 was	
assessed	and	compared	with	a	commonly	used	osteogenic	supplement,	Simvastatin.	
The	aims	of	this	chapter	are:	1)	to	pre-assess	the	effect	of	BMP2	at	a	physiological	level	
and	 compare	 with	 simvastatin	 as	 osteo-inducers	 in	 the	 perfusion	 three-dimensional	
bioprocess	previously	designed.	2)	to	establish	the	efficient	long-term	3D	bioprocess	in	
a	 perfusion-RWV	 bioreactor	 for	 directing	 the	 osteogenic	 differentiation	 of	 hDPSCs	
supplemented	with	minimal	concentrations	of	BMP2,	and	compare	it	with	the	effect	of	
simvastatin.	
The	pilot	study	of	 the	supplements	 in	growth	medium	allowed	to	determine	 if	 these	





Previously	 we	 demonstrated	 that	 hDPSCs	 long-term	 cultured	 in	 3D	 scaffolds	 in	 a	














For	 the	 differentiation	 in	 full	 media,	 donor	 samples	 of	 hDPSCs	 were	 expanded	




process,	 beads	 were	 transferred	 to	 perfusion-RWV	 bioreactor	 and	 for	 21	 days	
osteogenic	medium	containing	dexamethasone,	β-GP,	ascorbic	acid	and	KH2PO4,	and	
either	 300	 [pg/ml]	 of	 BMP2	 (experimental	 grop	 BMP2-2),	 or	 10	 uM	 of	 simvastatin	
(experimental	group	SIMV-2)	was	used	to	drive	undifferentiated	hDPSCs	to	osteogenic	
lineage.	Medium	perfusion	was	set	to	1	vessel	volume	per	day	(55	ml).	Thus	osteogenic	


















The	 osteogenic	 capability	 of	 the	 supplements	 was	 established	 by	 measuring	
proliferation,	 mineralisation	 through	 different	 techniques,	 and	 qualitatively	 by	 SEM	
microscopy,	histology	and	immunostaining.	
The	growth	kinetic	were	measured	by	the	ATP	content	and	MTS	activity	of	beads.	The	









































































































at	physiological	 level	or	 simvastatin.	 In	order	 to	 confirm	whether	 these	 tissues	were	




samples	 displayed	 a	 heterogeneous	 morphology.	 However,	 the	 two	 groups	 of	
osteogenic	constructs	showed	bone	neo-tissue	formation	over	the	time	period.	At	day	
1,	most	 cells	 appear	 scattered	 and	 spread	 homogenously	 through	 the	 beads	 (Figure	







area,	suggesting	a	 lower	degree	of	maturation	of	 the	cells.	 Interestingly,	 the	BMP2-1	
group	showed	the	appearance	of	lacunae	in	the	inner	area	of	the	beads,	meanwhile	the	
perfusion	 group	 with	 osteogenic	 media	 from	 the	 previous	 chapter	 by	 day	 14	 of	































(Figure	 74	 and	 Figure	 75).	 The	 two	 experimental	 groups	 by	 day	 14	 of	 culture	 under	
differentiation	 medium,	 produced	 tissue	 positive	 for	 osteopontin,	 osteocalcin,	
podoplanin	 and	 sclerostin,	 with	 the	 BMP2-1	 group	 showing	 higher	 intensity	 for	














hydrogels	 of	 both	 experimental	 groups	 after	 osteogenic	 culture.	 Additionally,	 the	
lacunae	seen	in	the	histology	are	seen	in	these	pictures,	along	with	the	morphogenesis	
of	 the	 osteoblastic	 cells.	 Pictures	 showed	 the	 presence	 of	 non-stoichiometric	
mineralised	 deposits.	 By	 day	 14	 the	 lacunae	 were	 distributed	 in	 some	 areas	 of	 the	














acclimatising	 of	 the	 cells	 to	 the	 3D	 environment	was	 performed	 for	 7	 days	 in	 static	
culture	 placed	 in	 a	 shaker.	 By	 day	 7,	 hydrogels	 were	 placed	 in	 the	 perfusion-RWV	
bioreactor.	Following	the	pilot	study,	two	new	experimental	groups	were	established	
and	studied,	BMP2-2	in	which	osteogenic	differentiation	of	hDPSCs	was	performed	by	
exposure	 to	osteogenic	medium	 (Dex,	ASAP,	β-GP)	 supplemented	with	300	pg/ml	of	
BMP2	for	21	more	days	and	SIMV-2,	in	which	osteogenic	differentiation	of	hDPSCs	was	
performed	by	exposure	to	osteogenic	medium	(Dex,	ASAP,	β-GP)	supplemented	with	10	
uM	of	 simvastatin	 for	 21	more	days.	 The	osteogenic	 capability	 of	 the	 supplemented	
osteogenic	 media	 was	 established	 by	 measuring	 proliferation,	 gene	 expression,	
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mineralisation	 through	 different	 techniques,	 and	 qualitatively	 by	 SEM	 microscopy,	
histology	and	immunostaining.	
Every	hydrogels	containing	osteogenic	cells	after	28	days	of	culture	showing	changing	






During	 the	 differentiation	 process,	 the	 morphology	 changes	 of	 the	 hydrogels	 were	
followed	by	light	microscopy.	By	day	7	(expansion	and	acclimatising	period),	cells	were	
likely	 to	 show	 single	 cell	 suspension	 well	 distributed	 through	 the	 hydrogel.	 The	
hydrogels	did	not	show	signal	of	mineralisation.	By	day	21	(day	14	of	differentiation),	
mineralisation	started	conquering	the	hydrogels,	and	light	almost	could	not	travel	across	
the	 hydrogels.	 By	 day	 28	 pictures	 show	 black	 spheres,	 as	 light	 did	 not	 cross	 the	
hydrogels.	From	the	two	experimental	groups,	mineralisation	appears	to	be	higher	 in	
the	BMP2-2	group.	Morphology	of	the	beads	can	be	seen	in	Figure	78.	
The	 growth	 kinetics	 of	 hDPSCs	 seeded	 in	 beads	 (n=6)	 for	 both	 experimental	 groups	
followed	a	simoid	growth	profile	with	the	appearance	of	distinct	lag,	exponential	and	
stationary	phases.	They	showed	that	by	day	28,	the	experimental	group	SIMV-2	yielded	















































































experimental	 group	 BMP2-2,	 glucose	 was	 consumed	 from	 ≈6.7	 [mmol/L]	 to	 ≈1.6	
[mmol/L]	and	approximately	twice	the	number	of	molecules	of	lactate	was	produced.	
Lactate	 accumulation	 was	 low	 through	 the	 experiment,	 only	 achieving	 readable	
measurements	by	 last	week	of	culture,	reaching	≈10.1	[mmol/L].	Glucose	and	lactate	
kinetics	for	experimental	group	BMP2-2	can	be	seen	in		Figure	81A.	In	the	experimental	
group	 SIMV-2,	 glucose	 was	 consumed	 from	 ≈6.7	 [mmol/L]	 to	 ≈1.7	 [mmol/L]	 and	
approximately	 twice	 the	 number	 of	 molecules	 of	 lactate	 was	 produced.	 Lactate	
accumulation	was	low	through	the	experiment,	only	achieving	readable	measurements	
























Figure	 81	 Change	 with	 culture	 time	 of	 key	 substrates	 and	 metabolites	 in	 culture	




Figure	 82	 Change	 with	 culture	 time	 of	 key	 substrates	 and	 metabolites	 in	 culture	























































































































































































In	order	 to	 confirm	whether	 these	 tissues	were	mineralised	bone	 tissue,	 histological	
analysis	 and	 immunostaining	was	 done	 to	 characterize	 the	morphology	 and	 calcium	
deposits	in	tissues.		
The	 resulting	 hydrogels	 from	 two	 experimental	 groups	 were	 cut	 in	 slices	 and	
histologically	examined	by	hematoxylin	and	eosin	staining	(H&E).	As	shown	in	Figure	83,	
samples	from	both	experimental	groups	displayed	a	more	homogeneous	morphology	
compared	 to	 the	 un-supplemented	 samples	 (Figure	 83F),	 however,	 the	 morphology	






from	the	surface	to	 the	 inner	area	of	 the	beads.	However,	both	SIMV-2	and	BMP2-2	
showed	 lacunae	 starting	 to	 form	 from	 the	 core	 area	 to	 the	 surface,	 suggesting	 that	
differentiation	 started	 earlier	 in	 the	 centre	 of	 the	 beads.	 BMP2-2	 resulted	 in	
homogeneous	 beads,	 totally	 populated	 by	 cells	 and	 their	 lacunae.	 By	 day	 21,	 fair	
formation	of	round-shaped	lacunae	was	seen,	and	increased	by	day	28	(see	Figure	83).	
This	 suggests	 cell	 maturation.	 SIMV-2	 group	 showed	 less	 differentiation	 than	 group	
BMP2-2.	By	day	21	less	lacunae	formation	was	observed,	suggesting	inferior	maturation	
of	 the	 cells.	 Additionally,	 hydrogels	 appear	 fully	 and	homogeneously	 populated	with	
cells.	Group	BMP2-2	showed	the	production	of	mature	morphology,	however,	most	of	
the	lacunae	is	circle-shaped	and	elongated	lacunae	was	scarce.	








Von	 kossa	 staining	 was	 done	 for	 day	 28	 and	 albeit	 the	 results	 do	 not	 show	 mass	





































Figure	 88	 Immunostaining	 for	 controls	 A)	 anti-osteocalcin	 (green)	 and	 anti-
osteopontin	 (red)	 undifferentiated	 beads,	 B)	 anti-sclerostin	 (green)	 and	 anti-
podoplanin		(red)	of	undifferentiated	beads	and	C)		anti-osteocalcin	(green)	and	anti-
osteopontin	 (red)	 negative	 control,	 B)	 anti-sclerostin	 (green)	 and	 anti-podoplanin		
(red)	of	negative	control.	
6.4.2.2 Quantitative	analysis	of	hDPSCs	3D	osteogenic	bioprocesses	
The	 quantitative	 comparisons	 among	 the	 supplements	 was	 undertaken	 by	 ALPase	








area	 in	 stained	 slides.	 Experimental	 group	 BMP2-2	 showed	 higher	 expression	 in	 the	





























































comparison	 of	 mineralisation	 in	 this	 study	 was	 based	 on	 the	 true	 calcified	
hydroxyapatite	components	(Figure	91,	Figure	92,	Figure	93,	Figure	94	and	Figure	95).	
They	were	characterised	 in	ATR-FTIR	by	 the	specific	 spectral	bands	at	1012	cm-1	and	
1445	cm-1	which	are	comparable	with	pure	hydroxyapatite	and	collagen	of	human	bone	






differentiation	 conditions.	 These	 low	 ratios	 represent	 non-stoichiometric	




the	 unsupplemented,	 could	 be	 a	 result	 of	 a	 cell-dense	 surface	 producing	 a	 more	































































































































































Figure	 95	 Measurement	 of	 hydroxyl	 apatite	 quality	 by	 X-ray	 microanalisis.	
Standardised	Ca/P	ratios	scored	by	Experimental	groups	BMP2-2	and	SIMV-2	by	day	

































Following	 the	 evaluation	 of	 the	 enzymatic	 and	 chemical	 characteristics	 of	 the	
biomaterial	 constructs	 formed	 by	 the	 two	 experimental	 groups,	 osteogenic	






















































































hydrogels	 of	 both	 experimental	 groups	 after	 osteogenic	 culture.	 Additionally,	 the	
lacunae	 seen	 in	 the	 histology	 are	 clearly	 viewed	 in	 these	 pictures,	 along	 with	 the	
morphogenesis	 of	 the	 osteoblastic	 cells.	 In	 the	 first	 days	 of	 culture,	 cells	were	 seen	
scattered	 homogenously,	 additionally,	 as	 ECM	was	 still	 not	 produced,	 the	 hydrogels	
were	weak	and	difficult	 to	process	 for	SEM.	After,	 scaffolds	 started	getting	 rigid	and	
pictures	 showed	 the	 presence	 of	 non-stoichiometric	 mineralised	 deposits.	 These	

























the	 in	 vivo-in	 vitro	 environments,	 for	 the	 production	 of	 neo-tissue-equivalents.	 Its	
strategy	involves	studying	cells,	3D	scaffolds/biomatrixes	and	the	design	of	bioreactors.	
In	due	process,	elaborating	the	framework	for	systemic	and	controlled	in	vitro	studies	
of	 tissue	development	and	 function.	To	date,	 several	 studies	 in	2D	and	3D	platforms	
have	been	done,	refining	the	technique	to	a	complex	bioprocess	to	produce	bone-like	




showing	 the	 potential	 use	 of	 MSCs	 in	 bone	 regeneration.	 The	 different	 strategies,	
	 185	
encapsulated	 cells	 (or	 cells	 seeded	 into	 a	 scaffold),	 semi-batch	 or	 perfused	 feeding	
strategies	 and	 shear	 stress	 modulation,	 showing	 successful	 results	 for	 osteogenic	




been	 introduced,	 providing	 culture	 systems	with	dynamic	 exchange	of	 nutrients	 and	
oxygen,	together	with	a	new	source	of	controlled	shear	stress.	Previously,	we	developed	
a	 culture	 system	 to	 create	 three-dimensional	 bone-like	 tissues	 based	 on	 hDPSCs,	
alginate/gelatin	bead,	and	perfusion-RWV	bioreactor	and	tested	its	performance	with	
regular	 osteogenic	 differentiation	 medium.	 Its	 comparative	 results	 exceeded	 the	
performance	obtained	with	static	culture	and	a	commercially	available	HARV	bioreactor.	
However,	 the	 transition	 from	 laboratory	 to	 the	clinic,	 requires	 the	production	of	 the	
homogeneous	and	constant	production	of	cellular	constructs,	cell	therapy	requires	the	
highest	quality	production.		Therefore,	we	studied	the	capability	of	supplement	BMP2	









were	 placed	 to	 culture	 in	 suspension	 environment	 within	 vessels	 of	 perfusion-RWV	
bioreactor	for	14	days	of	culture,	whereas	the	bioreactor	maintains	controlled	in	vitro	
culture	 conditions	 that	 permit	 tissue	 growth	 and	 development.	 Each	 day	 of	 culture,	








In	 the	 performed	 pilot	 study	 of	 the	 supplements,	 both	 supplements,	 BMP2	
(experimental	 group	 BMP2-1)	 and	 simvastatin	 (experimental	 group	 SIMV-1)	 in	
expansion	 medium,	 demonstrated	 to	 be	 able	 to	 produce	 bone	 differentiation.	
Experimental	group	SIMV-1	revealed	higher	cell	proliferation	and	viability.	Simvastatin	
has	 been	 seen	 to	 protect	 cells	 from	 cellular	 senescence	 induced	 by	 long-term	
cultures/passages	in	vitro	(Zanette	et	al.,	2015),	and	this	effect	could	be	the	underlying	
cause	 of	 the	 differences	 in	 viability.	 Implying	 that	 although	 differentiation	 inhibits	
proliferation,	 simvastatin	 could	 yield	 more	 cells	 than	 other	 bone	 differentiation	
supplements.		
Cell	growth	and	expression	of	the	osteoblastic	phenotype	in	2D	static	culture	has	three	
distinct	 phases:	 1)	 High	 proliferation	 and	 development	 of	 extracellular	 collagenous	
matrix	(10	to12	days).	2)	Matrix	maturation,	down-regulation	of	proliferation	and	up-







and	 ALPase	 activity.	 It	 showed	 that	 by	 day	 14,	 the	 scaffolds	 produced	 by	 the	 two	
experimental	groups	were	fully	populated	of	living	cells	and	presented	positive	ALPase	
activity.	The	two	groups	did	not	present	significant	differences	in	their	level	of	ALPase	





groups,	 the	 cell	 constructs	 during	 differentiation	 were	 characterised	 by	 histological,	
immuno-staining	and	SEM	microscopy.	Histological	H&E	staining	of	sectioned	hydrogels	
at	 day	 0,	 showed	 most	 cells	 appear	 scattered	 in	 the	 bead	 without	 having	 form	
extracellular	 matrix.	 After,	 displayed	 well	 distributed	 tissue	 growth	 for	 both	
experimental	groups.	Morphogenesis	of	the	osteogenic	cells	until	achieving	maturation,	
can	be	seen	in	both	experimental	groups	by	the	emergence	of	osteocyte	lacunae.	ARS	
staining	 indicated	 positive	 differentiation	 after	 the	 14	 day-long	 culture,	 a	 gradual	
enhancement	 in	 mineral	 deposition	 for	 the	 cell	 constructs	 produced	 by	 both	
experimental	groups	was	seen.	Von	Kossa	staining	was	poor	but	slightly	positive,	and	
confirmed	 the	 mineralisation	 by	 showing	 disperse	 deposits	 of	 calcium	 through	 the	
hydrogels	 for	 both	 groups.	 Immunostaining	 for	 osteopontin,	 osteocalcin,	 podoplanin	
and	sclerostin	was	positive	for	both	groups,	showing	cells	undergoing	bone	ontogenesis	
from	early	osteoblasts	to	mature	osteocytes.	
The	 surface	 of	 the	 cell	 constructs	 was	 analysed	 with	 SEM	 microscopy,	 here	 the	
morphogenesis	 of	 the	 hDPSCs	 can	 be	 perceived	 in	 different	 levels	 for	 the	 two	
experimental	 groups,	 BMP2-1	 showed	 higher	 neo-tissue	 maturation,	 seen	 by	 the	
hydroxyapatite	 crystals	 found,	 the	 osteocyte	 lacunae	 and	 the	 presence	 of	 immature	
osteocytes.	
The	 results	of	 the	pilot	 study	suggest	 that	both	 supplements	have	osteogenic	effect.	
Hence,	their	differentiability	in	full	osteogenic	media	was	further	assessed.	
Further	to	the	short	pilot	study,	we	investigated	the	capability	of	supplement	BMP2	at	
physiological	 level	 (experimental	 group	 BMP2-2)	 and	 compared	 with	 simvastatin	
(experimental	group	SIMV-2)	in	full	osteogenic	medium	for	long-term	culture.		hDPSCs	
were	 homogenously	 encapsulated	 within	 1.1%	 alginate	 mixed	 with	 0.1%	 gelatin	
hydrogels,	afterwards	the	encapsulated	hDPSCs	were	placed	to	culture	 in	suspension	














three	 staged	pattern	 previously	 described,	 and	 	 a	 similar	 behaviour	was	 seen	 in	 the	
proliferation	of	cells	in	both	experimental	groups,	but	with	a	time	delay,	this	could	be	
associated	 with	 the	 3D	 environment.	 The	 plateau	 observed	 in	 the	 cell	 proliferation	













It	 has	 been	 reported	 that	 the	 profile	 of	 pH	 and	 these	 metabolites	 can	 be	 used	 to	
modulate	 cell	 metabolism,	 for	 instance	 ECM	 deposition	 and	 neo-tissue	 progress	 for	




















glutamine	 consumption.	 We	 believe	 the	 decrease	 in	 the	 consumption	 of	 glutamine	









major	 role	 in	 SCs	 growth	 and	 differentiation,	 hypoxic	 conditions	 favouring	




For	 validation	 of	 the	 3D	 osteogenic	 differentiation	 achieved	 by	 both	 experimental	








the	 core	 to	 the	 surface,	 but	 not	 reaching	 the	 surface,	 as	 opposed	 with	 the	
unsupplemented	 culture	which	 produced	 lacunae	 from	 the	 surface	 to	 the	 core	 (see	
Figure	53).	ARS	staining	indicated	a	progressive	differentiation	through	time,	a	gradual	
enhancement	 in	 mineral	 deposition	 for	 the	 cell	 construct	 produced	 by	 both	
experimental	 groups.	 The	ARS	quantitative	 analysis	 is	 consistent	with	 the	qualitative	
results	 and	BMP2-2	group	 shows	better	performance	 than	SIMV-2	group.	Von	Kossa	
confirmed	 the	 mineralisation	 by	 showing	 scarce	 but	 positive	 disperse	 deposits	 of	
calcium	 through	 the	 hydrogels.	 Immunostaining	 for	 osteopontin,	 osteocalcin,	
podoplanin	and	sclerostin	was	positive	for	both	groups,	showing	cells	undergoing	bone	






surface	 of	 the	 cell	 constructs	 was	 analysed	 with	 SEM	 microscopy,	 here	 the	
morphogenesis	 of	 the	 hDPSCs	 can	 be	 perceived	 in	 different	 levels	 for	 both	 groups,	
where	osteoid	osteoblasts	and	mineralising	osteocytes	are	clearly	distinguished,	but	not	
mature	osteocytes	with	dendritic	processes	(canaliculi).	Both	groups	showed	high	neo-







of	 the	 inorganic	 fraction	 (hydroxyapatite),	 and	 the	 ratio	 of	 organic	 and	 inorganic	
component,	 C/P	 is	 characteristic	 biogenic	 signature	 for	 human	 bone.	 However,	 it	 is	
recommended	 to	 use	 the	 phosphate	 peak	 of	 1035	 and	 carbonate	 peak	 of	 1415	 to	
calculate	C/P	ratio.	When	these	wavenumbers	are	used,	the	human	bone	C/P	ratio	is	








biogenic	 signature	 of	 the	 inorganic	 fraction	 of	 bone	 (hydroxyapatite).	 Pure	
hydroxyapatite	has	a	Ca/P	ratio	of	1.67	(Medina	Ledo	et	al.,	2008).	In	our	experiments,	




values	 presented	 in	 the	 previous	 chapter,	 show	 a	 surface	 differentiation	 front	 with	
highly	calcified	surface,	less	calcified	interior.	More	research	should	be	done	until	the	
proper	 ratio	 is	 reached.	 This	 statement	 can	 be	 confirmed	with	 the	ATR-FTIR	 results,	
whish	measure	with	a	depth	of	penetration	of	up	to	5	[um],	against	the	0.1-2	[nm].	
3D	 osteogenesis	 was	 characterised	 at	 a	 genetic	 level,	 examining	 the	 expression	 of	
Runx2/CBFA1,	 osteocalcin	 (BGLAP),	 alkaline	 phosphatase	 (ALPL),	 collagen	 type	 I	
(COL1A1)	and	sclerostin	(SOST),	these	genes	are	representative	of	the	entire	MSCs	to	
osteocyte	ontogenesis.	Osteogenic	ontogenesis	requires	the	precise	and	orchestrated	
activity	 of	 several	 genes	 and	 signals	 (extracellular	 and	 intracellular).	 Runx2	 is	 a	
transcription	 factor	 and	 the	 central	 control	 of	 osteogenic	 differentiation.	 Its	
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upregulation	 happens	 early	 in	 the	 ontogenesis,	 and	 is	 believed	 to	 have	 a	 constant	





upregulation	 is	 characteristic	 of	 osteogenic	differentiation	 and	 can	be	 considered	an	
early	marker	of	differentiation.	Osteocalcin	(BGLAP),	is	an	osteoblast	specific	gene	and	
one	of	the	most	abundant	proteins	in	bone,	its	expression	is	significantly	upregulated	in	
matrix	 synthesis	 and	mineralisation	 (Ryoo	et	 al.,	 1997).	 Sclerostin	 (SOST)	 is	 a	 known	
specific	gene	for	mature	osteocytes,	and	It	is	integral	to	osteocyte	function	as	a	signal	
to	 damp	 the	 action	 of	 osteoblast	 bone	 deposition	 and	 to	 control	 bone	metabolism	
(Compton	and	Lee,	2014).	
MSCs,	preosteoblasts	and	osteoblasts	express	Runx2	together	with	secreting	osteoid,	
when	pre-osteoblasts	 go	 through	maturation,	 the	expression	alkaline	phosphatase	 is	
increased.	 When	 mature	 osteoblasts	 become	 embedded	 in	 osteoid,	 they	 express	





in	 the	 last	 week	 of	 culture	 could	 represent	 the	 further	 transition	 from	 mature	
osteoblasts	 to	 osteocytes.	 During	 all	 this	 period,	 Col1a1	 and	 ALPL	 were	 active	 and	
positive	with	a	6-time	fold	and	a	3	times	fold	increase.	These	genes	are	related	with	ECM	
formation	 and	 mineralisation,	 and	 are	 indicative	 of	 a	 well	 developed	 in	 vitro	
osteogenesis.	 These	 results	 suggest	 that	 a	 homogeneous	 population	 of	 cells	 was	
produced	 with	 cells	 in	 a	 mature	 osteoblastic	 and	 early	 osteocytic	 stage.	 SIMV-2	







increase	of	 SOST	 in	 the	 last	week	of	 culture	 could	 sustain	 this	 idea	of	maturation	 to	
osteocytes.	During	all	this	period,	Col1a1	was	low	positive,	meanwhile	ALPL	was	highly	
expressed.	 These	 genes	 are	 related	 with	 ECM	 formation	 and	 mineralisation,	 col1a1	
being	 an	 early	 marker,	 and	 ALPL	 a	 more	 mature	 and	 are	 indicative	 of	 late	 stage	
differentiation.	These	results	suggest	that	a	homogeneous	mostly	osteocytic	population	
of	cells	was	produced.		
BMP2-2	 group	 showed	 lower	 proliferation,	 higher	 calcification	 and	 a	 more	
homogeneous	bone	tissue	with	what	we	believe	to	be	population	of	mature	osteoblasts	
and	a	smaller	fraction	of	osteocytes.	SIMV-2	group	showed	a	higher	proliferation,	less	
calcified,	 with	 a	 less	 homogeneous	 construct,	 populated	 with	 what	 we	 believe	 is	 a	
mixture	of	osteoblasts	and	higher	fraction	of	early	osteocytes.	
The	 viability	 and	 proliferation,	 AP	 activity,	 gene	 expression,	 immunostaining,	 and	
calcium	 deposition	 observed	 in	 the	 BMP2-2	 group,	 along	 with	 the	 morphological	
analyses	done,	suggest	that	this	group	produced	a	homogeneous	construct	of	mature	
osteoblasts.	these	cells	are	active	cells	capable	of	proliferate,	secrete	osteoid,	calcify	and	
merge/	 consolidate	 with	 the	 in	 vivo	 environment.	 The	 more	 mature	 cell	 construct	
product	of	SIMV-2	group,	are	a	functional	cell	construct	rather	than	a	developmental	
cell	 construct.	 Hence,	 the	 merge/	 consolidation	 with	 in	 vivo	 tissue	 would	 be	 more	
difficult	to	achieve.	Sclerostin	producing	osteocytes	have	a	negative	effect	in	osteoblast	
proliferation	 and	 increase	 bone	 resorbing	 osteoclast	 presence	 and	 activity	 in	 the	





a	 suspended	 environment	 is	 successful	 in	 the	 mitigation	 of	 nutrient	 and	 oxygen	
transport	limitations,	external	to	three-dimensional	cell/alginate	constructs,	positively	






that	 this	 bioprocessing	 positively	 influences	 the	 proliferation,	 differentiation,	
mineralisation	and	expression	of	osteoblastic	markers	of	hDPSCs	cultured	in	the	absence	






increase	 in	 the	 Ca/P	 ratio,	 measured	 by	 SEM/EDS	 was	 poor	 and	 demonstrated	 the	
production	of	non-stoichiometric	hydroxyapatite,	previously	we	showed	better	results	
with	the	unsupplemented	bioprocess,	this	constructs	had	a	surface	differentiation	front,	
and	 produced	 a	 highly	 mineralised	 surface.	 Both	 experimental	 groups	 presented	 a	
homogeneous	 differentiation	 front,	 hence	 producing	 less	mineralised	 surface.	 These	
were	 qualitatively	 validated	 by	 immunostaining,	 H&E	 and	 von	 Kossa	 staining,	 SEM	
pictures	and	ATR-FTIR	imaging.	Experimental	group	BMP2-2	achieved	better	results	in	
most	of	the	analysis,	producing	a	well	mineralised	homogeneous	cell	construct,	mainly	




simvastatin	 described	 here,	 would	 provide	 an	 efficient	 and	 easy	 culture	 system	 for	
applications	in	bone	tissue	engineering	in	the	context	of	macroscopic	bone	neo-tissue	
formation.	In	particular,	the	successful	use	of	physiological	BMP2	promises	to	have	an	




















Mesenchymal	 stem	 cells	 from	 most	 tissues	 of	 the	 body	 have	 arisen	 as	 attractive	
therapeutic	tools	with	high	potential	in	regenerative	medicine.	Their	capability	to	give	
raise	to	a	variety	of	cell	types,	made	them	the	focus	of	extensive	research	to	produce	
biological	 substitute	 devices.	 hDPSCs	 are	 a	 particular	 source	 for	 adult	mesenchymal	
stem	cells.	They	present	ease	in	access	and	extraction,	high	proliferative	characteristics,	
bone	 tissue	 differentiability	 and	 they	 do	 not	 elicit	 ethical	 considerations,	 as	 their	
extraction	is	one	of	the	less	invasive	between	SCs.		
Tissue	 engineering	 encompasses	 the	 required	 toolset	 to	 process	 SCs	 into	 tissue	
constructs.	Through	the	crosstalk	between	cellular	biology	and	engineering,	it	attempts	
to	discover	the	missing	link	between	cells	and	the	 in	vivo	environment.	Ultimately,	to	




produce	 neo-tissue.	 b)	 the	 bio-signalling	 factor,	 comprising	 the	 cues	 and	 stimuli	 to	
sustain	 cells	 and	 drive	 their	 differentiation	 to	 the	 adequate	 lineage.	 C)	 the	
environmental	factor,	the	three	dimensional	area,	where	cells	inhabit	and	develop,	able	





Bone	 tissue	engineering,	would	be	 the	particular	 field	 researching	bone	healing.	The	
cells	able	to	differentiate	into	functional	osteogenic	cells,	producing	the	characteristic	
extracellular	 matrix.	 The	 required	 physical	 and	 chemical	 cues	 to	 drive	 bone	
differentiation.	The	 fabrication	of	 resorbable	 scaffolds	displaying	 suitable	mechanical	
and	 biological	 properties	 to	 replace	 large	 bone	 defects,	 and	 able	 to	 undergo	 neo-





However,	 this	 system	 was	 not	 appropriate	 for	 tissue	 development.	 Bone	 cells	 are	
enclosed	 in	 a	 3D	 complex	 histoarchitecture	 not	 reproducible	 in	 2D.	 Thus,	 in	 vivo	
reproducibility	 of	 the	 2D	 in	 vitro	 development	 is	 unfeasible.	 To	 confront	 the	
adimensionality	of	this	system,	3D	scaffolds	where	incorporated	into	the	system	and	TE	
continued	 to	 evolve	 towards	 the	 production	 of	 functional	 tissue	 substitutes.	
Nonetheless,	this	setting	provided	the	cells,	with	nutritional	diffusion	constrains,	hence	
requiring	 an	 adequate	 delivery	 system.	 Dynamic	 suspended	 culture	 bioreactors,	
wherein	the	cell/	scaffold	constructs	are	processed	under	controlled	conditions,	such	as	
nutritional	 requirements,	 temperature,	 pH	 and	 dissolved	 gases,	 appear	 to	 be	 the	
solution	to	this	hindrance	and	to	long-term	stem	cell	culture.	
In	this	thesis,	a	bioprocess	for	the	homogeneous	undifferentiated	expansion	and	further	
bone	 differentiation	 was	 established.	 The	 in-house	 designed	 perfusion	 system	
incorporated	 to	a	RWV	unit	provided:	a	convenient	gas-permeable	membrane	vessel	
casing	and	an	oxygenator	to	ensure	the	homogeneous,	efficient	and	constant	supply	of	
oxygen,	medium	perfusion	 to	 ensure	 adequate	nutrient	 supply	 and	metabolic	waste	
removal,	 and	 the	 avoidance	 of	 experimental	 error	 from	 manual	 operation	 by	 an	
automation	 system.	 These	 novel	 features,	 consequently,	 resulted	 in	 an	 effectively	
maintained	 culture	 condition	 throughout	 the	 entire	 long-term	 culture.	 Additionally,	
showing	 to	 be	 a	 convenient	 adaptation	 culture	 environment	 by	 controlling	 culturing	
factors	at	real	time.		
The	 bioprocess	 has	 successfully	 proven	 to	 be	 a	 significant	 improvement	 for	
maintenance,	expansion	and	osteogenic	differentiation	of	hDPSCs,	in	comparison	to	fed-

















These	 enhanced	 culture	 conditions	 successfully	 proven	 to	 significantly	 improve	 the	




Studies	 describing	 the	 3D	 undifferentiated	 expansion	 of	 hDPSCs	 in	 3D	 environment,	
under	 long-term	 culture	 have	not	 been	 found	 in	 Pubmed,	 EBSCO	or	Google	 scholar.	
Albeit	this	was	not	the	main	scope	of	this	research	project,	a	first	approximation	has	




production	 of	 undifferentiated	 hDPSCs	 for	 its	 further	 banking	 could	 provide	 ready-
availability	of	cells	for	any	cell	therapy	when	required,	and	the	impact	 in	the	medical	
market	 could	 be	 significant.	 Additionally,	 the	 proper	 control	 of	 cell	 density	 for	 cell	





Wang	 et	 al.,	 2003,	 Gomes	 et	 al.,	 2006,	 Hosseinkhani	 et	 al.,	 2006,	 Gao	 et	 al.,	 2016).	
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However,	 the	positive	 results	 shown,	were	 limited	by	 the	difficulties	 inherent	 to	 SCs	
processing,	heterogeneous	production	of	cells	and	an	ill-characterised	bone	construct	
(Sheehy	et	al.,	2015).	Most	of	 the	studies	done	 in	 this	 field,	procure	 to	demonstrate	
osteogenic	 differentiation	 with	 a	 limited	 number	 of	 widespread	 analyses:	 ALPase,	
proliferation,	 SEM	 microscopy,	 OC	 expression	 and	 histology	 and	 occasionally,	





are	 effective	 for	 characterising	 composition	 of	 the	 biomaterial.	 Mechanical	 loading	
testing	 should	be	performed	 in	 vitro	 and	 in	 vivo	 to	 assess	 the	materials	 response	 to	




of	 the	 produced	 tissue,	 which	 stage	 of	 differentiation	 is	 accomplished	 and	 how	
homogeneous	 the	 cell	 constructs	 are.	 The	 cell-types	 will	 be	 determining	 of	 the	
applicability	 of	 the	 therapy.	 In	 this	 project,	 that	 extra	 layer	 of	 characterisation	 was	
applied	 to	 the	 validation	 of	 the	 cell-constructs	 produced	 by	 the	 in-house	 designed	
bioreactor.	Spotting	structural	features,	as	well	as	specific	markers	(genes	and	proteins)	
of	bone	turnover	unique	to	each	stage/	cell	type,	measuring	viability,	enzymatic	activity	
and	 composition	 of	 the	 cell	 constructs.	 Additionally,	 the	 nutritional	 aspects	 of	 the	
system	were	 assessed	 following	metabolic	 kinetics	 of	 key	 nutrients	 and	 cellular	 by-
products.	Mechanical	 testing	was	 not	 performed,	 but	 future	work	 should	 include	 its	
measurement.	 By	 following	 this	 characterisation,	 the	 production	 of	 homogeneous	
mineralised	 tissue,	 rich	 in	 either	 osteoblasts	 or	 osteocytes	 was	 established.	 Cell	
construct	 Homogeneity	 plays	 a	 key	 role,	 as	 fully	 matured	 osteocytes,	 would	 bring	

















of	 cell	 therapy	 products	 and	 of	 the	 facilities,	 equipment,	 materials	 and	 quality	
assurance:	control,	validation,	qualification	and	documentation	(Giancola	et	al.,	2012).	
It	 would	 require	 for	 the	 culture	 media	 to	 be	 fully-defined	 and	 not	 containing	 any	
exogenous	materials,	a	single	step	closed	setup	bioprocess	in	a	clinical	setup.	
For	validation	and	assessment	of	the	neotissue	constructs	efficacy	and	safety,	an	in	vivo	
model	 should	 be	 done.	 A	 preclinical	 study	 to	 assess	 bone	 union	 after	 implantation	
(osseointegration),	osteoconduction,	vascularisation	and	the	physical	properties	of	the	
resulting	implant	should	be	performed.	Critical-size	defects	should	be	treated	with	cell	
therapy	 and	 then	 assessed	 for:	 biochemical	 markers	 of	 bone	 turnover,	 bone/mass	
density	 measurement,	 analysis	 of	 bone	 architecture/histology,	 and	 biomechanical	









provide	 new	 advantages	 in	 the	 field,	 it	 is	 arguable	 that	 they	 would	 bring	 higher	
processing	complexity	for	the	operators	and	set	back	the	possibility	of	automation.		
In	 the	 future,	 the	 adequate	bioprocess	would	be	 a	 single	 step	 closed	 setup.	Able	 to	
process	patient	cells	in	a	fully	automated	routine.	Starting	from	scaffold	seeding,	until	




role.	 Additionally,	 producing	 tissue	 implants	 in	 hospitals	 would	 elude	 logistical	
complication,	as	transferring	specimens	amid	different	locations.	Good	manufacturing	
practices	should	be	tightly	followed.	Additionally,	the	tissue	mimics	should	be	amenable	
for	 long	 term	 storage,	 allowing	 the	 prompt	 availability	 of	 tissue	 for	 emergency	
transplants	when	a	patient	custom	made	cell	construct	is	not	possible,	or	is	not	timely	
feasible.	Research	is	still	on	demand	to	reach	a	point	where	safety	cell	constructs	are	

















Although	 numerous	 major	 progresses	 have	 been	 introduced	 in	 the	 bone	 tissue	
engineering	field,	current	bioprocessing	still	faces	many	shortcomings,	and	no	adequate	
substitutes	have	been	developed.	Bone	tissue	is	complex,	its	development	and	healing	
involves	 an	 entangled	 network	 of	 growth	 factors,	 working	 in	 joint	 effort	 with	
multipotent	cells	 in	a	characteristic	environment.	Knowledge	 is	 limited	and	unknown	
factors	yet	need	to	be	discovered.	
Development	 in	 cell	 sources,	 signalling	 molecules,	 scaffolds	 and	 bioreactor	 could	
provide,	 the	 means	 to	 close	 the	 in	 vitro/	 in	 vivo	 gap,	 and	 help	 the	 transfer	 of	 the	
mimicking	 devices	 developed,	 to	 a	 clinical	 setting.	 Additionally,	 the	 tight	 good	
manufacturing	practices	are	required	to	be	followed.		
Future	studies	in	our	perfusion	system,	to	produce	the	homogeneous	bone	replacement	






affect	 integrity,	 effectiveness	 and	 the	 availability	 of	 growth	 factors	 for	 bone	
differentiation	in	long	periods	of	culture.	






where	 the	 perfusion	 system	 resides.	 Finding	 the	 adequate	 strategy	 for	 hypoxic	
expansion	 and	 normoxic	 differentiation,	 could	 yield	 a	 better	 bone	 construct.	
Additionally,	osteogenic	tissue	is	acknowledged	to	be	sensitive	to	mechanical	stimuli	in	
vivo	 and	 in	 vitro,	 numerous	 studies	 have	 incorporated	 mechanical	 stimuli	 to	 their	
designs,	with	interesting	results.	Suggesting	that	incorporating	a	convenient	ultrasound	
	 204	
prove	 to	 the	 existing	 perfusion-RWV	 system,	 could	 yield	 enhanced	 bone	 construct	
production.	Alternatively,	it	has	been	reported	that	low	level	light	irradiation	(LLLI)	and	
pulsed	electro-magnetic	field	(PEMF)	have	an	effect	on	the	proliferation	and	osteogenic	
differentiation	 of	 MSCs.	 Attaching	 a	 red-light	 light	 emitting	 diode	 (LED)	 irradiation	
system	to	the	vessel	wouldn’t	be	difficult,	as	the	membrane	case	is	suitably	transparent	










Serum	 free,	 xeno	 free	 and	 chemically	 defined	 medium	 experiments	 should	 be	













variable	 and	 it’s	 unclear	 how	 the	 phenotypes	 defining	 MSCs	 as	 well	 as	 donor	
characteristics	(e.g.	age,	gender)	affect	their	functional	properties.	Studying	the	intrinsic	




the	optimal	 production	of	 clinically	 utilisable	 bone	 cell	 devices.	However,	 the	 ready-
availability	 of	 cellular	 constructs	 is	 as	 vital	 as	 the	 quality	 of	 the	 constructs.	 Hence,	
studying	 the	 long	 term	 storage	 of	 scaffolds	 loaded	 with	 cells	 undifferentiated	 and	
differentiated,	would	pose	 invaluable.	Methodologies	 of	 storage,	 along	with	 viability	
and	maintenance	of	undifferentiated	and	differentiated	phenotype	of	cells	should	be	
studied.	 Currently	 there	 are	 different	 storage	 methodologies,	 some	 use	
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